EurekaMag PDF full texts Chapter 46,290

Meda, H.A.; Doua, F.; Laveissière, C.; Miezan, T.W.; Gaens, E.; Brattegaard, K.; de Muynck, A.; De Cock, K.M. 1995: Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d'Ivoire. Transactions of the Royal Society of Tropical Medicine and Hygiene 89(6): 639-643

Morgan, M.B.; Viloria, J.; Morgan, J.D.; Suarez-Hoyos, J. 1994: Human immunodeficiency virus infection and hypereosinophilic syndrome. An increasingly recognized association. Journal of the Florida Medical Association 81(6): 401-402

Manoff, S.B.; Vlahov, D.; Herskowitz, A.; Solomon, L.; Muñoz, A.; Cohn, S.; Willoughby, S.B.; Nelson, K.E. 1996: Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology 7(6): 566-570

Bell, D.M. 1996: Human immunodeficiency virus infection and needle stick injuries. Pediatric Infectious Disease Journal 15(3): 277-278

Rao, T.K. 2001: Human immunodeficiency virus infection and renal failure. Infectious Disease Clinics of North America 15(3): 833-850

Reyes, J.C.; Robles, R.R.; Colón, H.M.; Matos, T.D.; Sahai, H.; Freeman, D.H. 1993: Human immunodeficiency virus infection and risk behaviors among injection drug users in four Puerto Rican communities. Puerto Rico Health Sciences Journal 12(1): 19-25

Uvin, S.C.; Flanigan, T.P. 1997: Human immunodeficiency virus infection and sexually transmitted diseases. Medicine and Health Rhode Island 80(10): 334-337

Kind, G.M.; VonRoenn, J.; Jansen, D.A.; Bailey, M.H.; Lewis, V.L. 1996: Human immunodeficiency virus infection and subsequent melanoma. Annals of Plastic Surgery 37(3): 273-277

Laroche, R.; Jeandel, P. 1995: Human immunodeficiency virus infection and surgery in the tropics: what risks, what kind of prevention?. Medecine Tropicale: Revue du Corps de Sante Colonial 55(4): 303-304

Lambert, M.; De Nayer, P. 1993: Human immunodeficiency virus infection and the thyroid tests. Annales de Medecine Interne 144(1): 47-50

Bryt, A.B.; Rogers, D.E. 1994: Human immunodeficiency virus infection and tuberculosis: an analysis and a course of action. Bulletin of the new York Academy of Medicine 71(1): 18-36

Moreno Guillén, S. 1994: Human immunodeficiency virus infection and tuberculosis: who should receive chemoprophylaxis?. Revista Clinica Espanola 194(2): 73-74

Peña, J.M. 2000: Human immunodeficiency virus infection and "Recommendations 2000". a step forward on the line of long-term therapeutic strategies. Enfermedades Infecciosas y Microbiologia Clinica 18(7): 307-309

Warren, N.; Bellin, E.; Zoloth, S.; Safyer, S. 1994: Human immunodeficiency virus infection care is unavailable to inmates on release from jail. Archives of Family Medicine 3(10): 894-898

Mejia, C.; Samcam, M.E.; Rodas, A.; Navarro, A.; Quinonez, E.; Zaydee, F.; Arathoon, E.; De Villatoro, E.; Pezzarossi, H.; Ramirez 1992: Human immunodeficiency virus infection in Guatemala. Revista del Colegio de Medicos y Cirujanos de Guatemala 2 Suppl: 9-13

Noroski, L.M. 1997: Human immunodeficiency virus infection in a patient with primary immunodeficiency. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 79(4): 281-282

Lakshmi, V.; Teja, V.D.; Rani, T.S.; Subhadha, K.; Upadhyaya, A.C.; Shantaram, V. 1998: Human immunodeficiency virus infection in a tertiary care hospital--clinical and microbiological profile. Journal of the Association of Physicians of India 46(4): 363-367

Echevarría, S.; Hernández, M.; Paz, I.; Galarraga, C.; Ledesma, F.; Martínez Bernal, M.A. 1994: Human immunodeficiency virus infection in an emergency department. Revista Clinica Espanola 194(7): 526-529

Ching, V.; Ritz, M.; Song, C.; De Aguir, G.; Mohanlal, P. 1996: Human immunodeficiency virus infection in an emergency hand service. Journal of Hand Surgery 21(4): 696-699

Mellado Peña, M.J.; Cilleruelo Ortega, M.J.; Villota Arrieta, J.; García López, M.; Pérez Jurado, M.L.; Barreiro Casal, G.; Veiga de Cabo, J.; Martín Fontelos, P. 1997: Human immunodeficiency virus infection in children. Clinical and immunological markers of disease progression. Anales Espanoles de Pediatria 47(4): 363-368

Shen, M.C.; Hu, F.C.; Lin, J.S.; Hsie, S.W.; Hung, C.C.; Chung, C.Y. 1998: Human immunodeficiency virus infection in haemophiliacs in Taiwan: the importance of CD4 lymphocyte count in the progression to acquired immunodeficiency syndrome. Haemophilia: the Official Journal of the World Federation of Hemophilia 4(2): 115-121

Brandt, C.D.; Rakusan, T.A.; Sison, A.V.; Saxena, E.S.; Ellaurie, M.; Sever, J.L. 1994: Human immunodeficiency virus infection in infants during the first 2 months of life. Reliable detection and evidence of in utero transmission. Archives of Pediatrics and Adolescent Medicine 148(3): 250-254

Carreras, R.; Fusté, P.; Checa, M.A.; Fernández, I. 1997: Human immunodeficiency virus infection in patients with intraepithelial squamous lesion of high histologic degree. Medicina Clinica 109(19): 772

D'Ercole, C.; Cravello, L.; Spérandéo, D.; Bretelle, F.; Piechon, L.; Boubli, L.; Blanc, B. 1996: Human immunodeficiency virus infection in pregnancy. General aspects. Presse Medicale 25(2): 77-80

Dabis, F. 1998: Human immunodeficiency virus infection in pregnant women in Africa. Revue d'Epidemiologie et de Sante Publique 46(1): 3-4

Rovira, M.T.; Antorn, M.T.; Payá, A.; Castellanos, E.; Mur, A.; Carreras, R. 2001: Human immunodeficiency virus infection in pregnant women, transmission and zidovudine therapy. European Journal of Obstetrics Gynecology and Reproductive Biology 97(1): 46-49

Hooi, L.S. 1993: Human immunodeficiency virus infection in recipients of living unrelated donor renal transplants--a report of 4 cases. Medical Journal of Malaysia 48(2): 232-235

González, E.; Herrero, M. 2000: Human immunodeficiency virus infection in rural practice. Archives of Family Medicine 9(9): 790-791

Fox, R.A.; Isenberg, D.A. 1997: Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis and Rheumatism 40(6): 1168-1172

Gallego Deike, L. 2000: Human immunodeficiency virus infection in the era of highly active antiretroviral therapy: need for a multidisciplinary focus. Medicina Clinica 115(15): 576-578

Bradley-Springer, L. 1993: Human immunodeficiency virus infection in the healthcare worker. Journal of the Association of Nurses in Aids Care: Janac 4(1): 37-47

Patrick, S.L.; Wright, T.C.; Fox, H.E.; Ginsberg, H.S. 1993: Human immunodeficiency virus infection of early passage cervical epithelial cultures. International Journal of Std and Aids 4(6): 342-345

Campbell, D.G.; Stephenson, A.J.; Li, P.; Oakeshott, R.D. 1996: Human immunodeficiency virus infection of human bone derived cells. Clinical Orthopaedics and Related Research 331: 291-299

Fuchs, D.; Dierich, M.P.; Wachter, H. 1994: Human immunodeficiency virus infection of the nervous system. Annals of Neurology 35(1): 125-126

Sultan, J.; Gaur, S.; Sandhaus, L.; Frenkel, L.D.; Ettinger, L.J. 1994: Human immunodeficiency virus infection presenting as pancytopenia in an infant. American Journal of Pediatric Hematology/Oncology 16(4): 334-337

Wong, S.N.; Khoo, S.W. 2001: Human immunodeficiency virus infection presenting with chronic actinic dermatitis: a case report. Annals of the Academy of Medicine Singapore 30(6): 664-667

Erickson, J.R. 1997: Human immunodeficiency virus infection risk among female sex partners of intravenous drug users in southern Arizona. Holistic Nursing Practice 11(2): 9-17

Miller, L.G.; Chang, E.S. 2002: Human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy: denial of poor medication adherence or recalcitrant infection?. Aids Patient Care and Stds 16(8): 355-359

Horowitz, H.W.; Telzak, E.E.; Sepkowitz, K.A.; Wormser, G.P. 1998: Human immunodeficiency virus infection, Part i. Disease-A-Month: Dm 44(10): 545-606

Horowitz, H.W.; Telzak, E.E.; Sepkowitz, K.A.; Wormser, G.P. 1998: Human immunodeficiency virus infection, Part II. Disease-A-Month: Dm 44(12): 677-716

Asherson, R.A.; Shoenfeld, Y. 2003: Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. Journal of Rheumatology 30(2): 214-219

Yoshida, E.M.; Chan, N.H.; Herrick, R.A.; Amar, J.N.; Sestak, P.M.; Willoughby, B.C.; Whittaker, J.S. 1996: Human immunodeficiency virus infection, the acquired immunodeficiency syndrome, and inflammatory bowel disease. Journal of Clinical Gastroenterology 23(1): 24-28

Velhal, G.D.; Bichile, S.K. 1999: Human immunodeficiency virus infection--trends and problems. Journal of the Association of Physicians of India 47(3): 261-262

Ribera, J.M. 1999: Human immunodeficiency virus infection-related lymphoma. Medicina Clinica 113(9): 349-356

Westphal, S.A.; Sarosi, G.A. 1994: Diabetic ketoacidosis associated with pulmonary coccidioidomycosis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 18(6): 974-978

Rodrigo, F.G.; Rodrigo, A.G. 2002: Human immunodeficiency virus infection. Dermatologic perspective. Acta Medica Portuguesa 15(4): 293-309

McCullough, M.J.; Firth, N.A.; Reade, P.C. 1997: Human immunodeficiency virus infection: a review of the mode of infection, pathogenesis, disease course, and the general and clinical manifestations. Australian Dental Journal 42(1): 30-37

Anonymous 1993: Human immunodeficiency virus infection: physicians' responsibilities. ACOG Committee Opinion No. 130. ACOG committee opinion No. 130: 4 p

Anonymous 1994: Human immunodeficiency virus infection: physicians' responsibilities. ACOG Committee Opinion: Committee on Ethics number 130--November 1993. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 44(1): 88-91

Clumeck, N. 1996: Human immunodeficiency virus infection: physiopathological approach to specific therapeutic strategies. Revue Medicale de Bruxelles 17(4): 164-166

Raj, R.; Verghese, A. 2000: Human immunodeficiency virus infections in adolescents. Adolescent Medicine 11(2): 359-374

Anonymous 1993: Human immunodeficiency virus infections. ACOG technical bulletin number 169--June 1992. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 41(3): 307-319

Nandwani, R. 1994: Human immunodeficiency virus medicine for the MRCP short cases. British Journal of Hospital Medicine 51(7): 353-356

Chung, C.W.; Rapuano, C.J.; Laibson, P.R.; Lytle, R.E.; Quirk, J.T.; Cohen, E.J. 2001: Human immunodeficiency virus p24 antigen testing in cornea donors. Cornea 20(3): 277-280

Bell, D.M.; Gerberding, J.L. 1997: Human immunodeficiency virus postexposure management of healthcare workers: report of a workshop. American Journal of Medicine 102(5b): 1-3

Merchant, R.C.; Keshavarz, R. 2001: Human immunodeficiency virus postexposure prophylaxis for adolescents and children. Pediatrics 108(2): E38

Coates, T.J.; Ehrhardt, A.A.; Celentano, D.D. 2000: Human immunodeficiency virus prevention: applying the lessons learned. Aids Clinical Review 2000: 1-22

Hoog, S.S.; Towler, E.M.; Zhao, B.; Doyle, M.L.; Debouck, C.; Abdel-Meguid, S.S. 1996: Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity. Biochemistry 35(32): 10279-10286

Mayers, D.; Bethel, J.; Wainberg, M.A.; Weislow, O.; Schnittman, S. 1998: Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study Group. Journal of Infectious Diseases 177(6): 1730-1733

Phillips, A.N.; Staszewski, S.; Lampe, F.; Youle, M.S.; Klauke, S.; Bickel, M.; Sabin, C.A.; Doerr, H.Wilhelm.; Johnson, M.A.; Loveday, C.; Miller, V. 2002: Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression. Journal of Infectious Diseases 186(8): 1086-1091

Strair, R.K.; Medina, D.J. 1996: Human immunodeficiency virus replication in the presence of antiretroviral drugs: analogies to antineoplastic drug resistance. Cancer Treatment and Research 87: 225-239

Karmochkine, M.; Descamps, D. 1999: Human immunodeficiency virus resistance to antiretroviral drugs. Annales de Medecine Interne 150(8): 615-622

Perkin, R.L. 1993: Human immunodeficiency virus revisited. Canadian Family Physician Medecin de Famille Canadien 39: 2507-2508

Martin, F.; Murphy, P. 1997: Human immunodeficiency virus risk awareness. Evaluation of a CME program for family physicians. Canadian Family Physician Medecin de Famille Canadien 43: 1382-1387

Mac-Seing, M.; Zarowsky, C. 2017: A meta-synthesis on gender, disability and reproductive health in sub-Saharan Africa. Sante Publique 29(6): 909-919

Calonge, B.N.; Petersen, L.R.; Miller, R.S.; Marshall, G. 1993: Human immunodeficiency virus seroprevalence in primary care practices in the United States. Western Journal of Medicine 158(2): 148-152

Mandalakas, A.M.; Guay, L.; Musoke, P.; Carroll-Pankhurst, C.; Olness, K.N. 1999: Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children. Pediatrics 103(2): E21

Hughes, L.A.; Bailey, M.H. 1993: Human immunodeficiency virus status in facial fracture patients. Plastic and Reconstructive Surgery 91(4): 577-580

Weinhardt, L.S.; Carey, M.P. 2000: Human immunodeficiency virus testing and behavior change. Archives of Internal Medicine 160(10): 1538-1539

LaPorte, D.M.; Mont, M.A.; Jones, L.C.; Padden, D.A.; Hungerford, D.S. 2001: Human immunodeficiency virus testing for elective orthopedic procedures: results in a community-based hospital. Orthopedics 24(1): 52-55

Nicolosi, A. 1993: Human immunodeficiency virus transmission and oral contraceptives. Journal of Infectious Diseases 167(5): 1256-1258

Rhodes, R.S. 1995: Human immunodeficiency virus transmission and surgeons: update. Southern Medical Journal 88(3): 251-255

Wright, J.G.; McGeer, A. 1993: Human immunodeficiency virus transmission between surgeons and patients in orthopaedic surgery. Clinical Orthopaedics and Related Research 297: 272-281

Anonymous 1994: Human immunodeficiency virus transmission in household settings--United States. Mmwr. Morbidity and Mortality Weekly Report 43(19): 347 353-6

Saha, K.; Caruso, M.; Volsky, D.J. 1997: Human immunodeficiency virus type 1 (HIV-1) infection of herpesvirus saimiri-immortalized human CD4-positive T lymphoblastoid cells: evidence of enhanced HIV-1 replication and cytopathic effects caused by endogenous interferon-gamma. Virology 231(1): 1-9

Geretti, A.M.; Dings, M.E.; van Els, C.A.; van Baalen, C.A.; Wijnholds, F.J.; Borleffs, J.C.; Osterhaus, A.D. 1996: Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons. Journal of Infectious Diseases 174(1): 34-45

Chazal, N.; Gay, B.; Carrière, C.; Tournier, J.; Boulanger, P. 1995: Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. Journal of Virology 69(1): 365-375

Schwartz, O.; Dautry-Varsat, A.; Goud, B.; Maréchal, V.; Subtil, A.; Heard, J.M.; Danos, O. 1995: Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. Journal of Virology 69(1): 528-533

Bandres, J.C.; Ratner, L. 1994: Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. Journal of Virology 68(5): 3243-3249

Fischer, M.; Günthard, H.F.; Opravil, M.; Joos, B.; Huber, W.; Bisset, L.R.; Ott, P.; Böni, J.; Weber, R.; Cone, R.W. 2000: Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy. Aids Research and Human Retroviruses 16(12): 1135-1140

Gruber, A.; Lell, C.P.; Speth, C.; Stoiber, H.; Lass-Flörl, C.; Sonneborn, A.; Ernst, J.F.; Dierich, M.P.; Würzner, R. 2001: Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro. Immunology 104(4): 455-461

Kao, S.; Akari, H.; Khan, M.A.; Dettenhofer, M.; Yu, X.-F.; Strebel, K. 2003: Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection. Journal of Virology 77(2): 1131-1140

Baraz, L.; Friedler, A.; Blumenzweig, I.; Nussinuv, O.; Chen, N.; Steinitz, M.; Gilon, C.; Kotler, M. 1998: Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production. Febs Letters 441(3): 419-426

Hrimech, M.; Yao, X-Jian.; Branton, P.E.; Cohen, E.A. 2002: Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. EMBO Journal 21(14): 3918

Chen, M.Y.; Maldarelli, F.; Karczewski, M.K.; Willey, R.L.; Strebel, K. 1993: Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity. Journal of Virology 67(7): 3877-3884

Larder, B.A.; Kohli, A.; Bloor, S.; Kemp, S.D.; Harrigan, P.R.; Schooley, R.T.; Lange, J.M.; Pennington, K.N.; St Clair, M.H. 1996: Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. the protocol 34,225-02 Collaborative Group. Journal of Virology 70(9): 5922-5929

Arp, J.; Rovinski, B.; Sambhara, S.; Tartaglia, J.; Dekaban, G. 1999: Human immunodeficiency virus type 1 envelope-specific cytotoxic T lymphocytes response dynamics after prime-boost vaccine regimens with human immunodeficiency virus type 1 canarypox and pseudovirions. Viral Immunology 12(4): 281-296

Lopalco, L.; De Santis, C.; Meneveri, R.; Longhi, R.; Ginelli, E.; Grassi, F.; Siccardi, A.G.; Beretta, A. 1993: Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class i alpha 1 peptide-binding domain. European Journal of Immunology 23(8): 2016-2021

Fonjungo, P.N.; Mpoudi, E.N.; Torimiro, J.N.; Alemnji, G.A.; Eno, L.T.; Lyonga, E.J.; Nkengasong, J.N.; Lal, R.B.; Rayfield, M.; Kalish, M.L.; Folks, T.M.; Pieniazek, D. 2002: Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features. Journal of Clinical Microbiology 40(3): 837-845

Faust, E.A.; Acel, A.; Udashkin, B.; Wainberg, M.A. 1995: Human immunodeficiency virus type 1 integrase stabilizes a linearized HIV-1 LTR plasmid in vivo. Biochemistry and Molecular Biology International 36(4): 745-758

Wiskerchen, M.; Muesing, M.A. 1995: Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. Journal of Virology 69(1): 376-386

Buckman, J.S.; Bosche, W.J.; Gorelick, R.J. 2003: Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. Journal of Virology 77(2): 1469-1480

Sluis-Cremer, N.; Dmitrienko, G.I.; Balzarini, J.; Camarasa, M.J.; Parniak, M.A. 2000: Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine. Biochemistry 39(6): 1427-1433

Pope, M.; Frankel, S.S.; Mascola, J.R.; Trkola, A.; Isdell, F.; Birx, D.L.; Burke, D.S.; Ho, D.D.; Moore, J.P. 1997: Human immunodeficiency virus type 1 strains of subtypes B and e replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism. Journal of Virology 71(10): 8001-8007

Kurosu, T.; Mukai, T.; Komoto, S.; Ibrahim, M.S.; Li, Y.-G.; Kobayashi, T.; Tsuji, S.; Ikuta, K. 2002: Human immunodeficiency virus type 1 subtype C exhibits higher transactivation activity of Tat than subtypes B and e. Microbiology and Immunology 46(11): 787-799

Cornelissen, M.; Kampinga, G.; Zorgdrager, F.; Goudsmit, J. 1996: Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. the UNAIDS Network for HIV Isolation and Characterization. Journal of Virology 70(11): 8209-8212

Handa, N. 1999: Human immunodeficiency virus type 1, type 2. Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 372-378

Ramezani, A.; Hawley, R.G. 2003: Human immunodeficiency virus type 1-based vectors for gene delivery to human hematopoietic stem cells. Methods in Molecular Medicine 76: 467-492

Li, H.; Haviv, Y.S.; Derdeyn, C.A.; Lam, J.; Coolidge, C.; Hunter, E.; Curiel, D.T.; Blackwell, J.L. 2001: Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles. Human Gene Therapy 12(18): 2155-2165

Cheng, L.; Chaidhawangul, S.; Wong-Staal, F.; Gilbert, J.; Poeschla, E.; Toyoguchi, M.; El-Bradey, M.; Bergeron-Lynn, G.; Soules, K.A.; Freeman, W.R. 2002: Human immunodeficiency virus type 2 (HIV-2) vector-mediated in vivo gene transfer into adult rabbit retina. Current Eye Research 24(3): 196-201

Mansinho, K. 1999: Human immunodeficiency virus type 2 infection. Acta Medica Portuguesa 12(12): 367-370

Carballo, E.; Aguilera, A.; Regueiro, B.; Barrio, E. 1994: Human immunodeficiency virus type 2 infection in 2 seamen of the northwest of Spain. Medicina Clinica 102(3): 101-103

Machuca, A.; Soriano, V.; Guti rrez, M.; Holguín, A.; Aguilera, A.; Caballero, E.; Cilla, G. 1999: Human immunodeficiency virus type 2 infection in Spain. the HIV-2 Spanish Study Group. Intervirology 42(1): 37-42

D'Aquila, R.T. 1996: Human immunodeficiency virus type 2: human biology of the other AIDS virus. Current Clinical Topics in Infectious Diseases 16: 84-101

Harrod, R.; Nacsa, J.; Van Lint, C.; Hansen, J.; Karpova, T.; McNally, J.; Franchini, G. 2003: Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription. Journal of Biological Chemistry 278(14): 12310-12318

Suga, S.; Tsurudome, M.; Ito, M.; Ohgimoto, S.; Tabata, N.; Nishio, M.; Kawano, M.; Komada, H.; Ito, M.; Sakurai, M.; Ito, Y. 1997: Human immunodeficiency virus type-1 envelope glycoprotein gp120 induces expression of fusion regulatory protein (FRP)-1/CD98 on CD4+ T cells: a possible regulatory mechanism of HIV-induced syncytium formation. Medical Microbiology and Immunology 185(4): 237-243

Al-Harthi, L.; Roebuck, K.A. 1998: Human immunodeficiency virus type-1 transcription: role of the 5'-untranslated leader region (review). International Journal of Molecular Medicine 1(5): 875-881

Odaibo, G.N.; Olaleyé, O.D.; Tomori, O. 1998: Human immunodeficiency virus types 1 and 2 infection in some rural areas of Nigeria. Romanian Journal of Virology 49(1-4): 89-95

Bolognesi, D.P. 1993: Human immunodeficiency virus vaccines. Advances in Virus Research 42: 103-148

Buss, W.G. 1992: Human immunodeficiency virus, the legal meaning of "handicap," and implications for public education under federal law at the dawn of the age of the ADA. Iowa law review 77(4): 1389-1508

Kitamura, T. 1993: Human immunodeficiency virus--its virological characteristics. Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 21-26

Thomas, C.A.; Weinberger, O.K.; Ziegler, B.L.; Greenberg, S.; Schieren, I.; Silverstein, S.C.; El Khoury, J. 1997: Human immunodeficiency virus-1 env impairs Fc receptor-mediated phagocytosis via a cyclic adenosine monophosphate-dependent mechanism. Blood 90(9): 3760-3765

Facchini, S.A.; Harding, S.A.; Waldron, R.L. 2002: Human immunodeficiency virus-1 infection and multiple sclerosis-like illness in a child. Pediatric Neurology 26(3): 231-235

Rouzioux, C.; Burgard, M.; Chaix, M.L.; Delamare, C.; Cirau, N.; Bouiller, B.; Cateloy, S.; Allemon, M.C.; Broyart, C.; Ciraru, N.; Floch, C.; Lelorier, P.; Lachassine, E.; Mazy, F.; Narcy, P.; Saillant, J.; Salomon, J.L.; Seaume, H.; Talon, P.; Mayaux, M.J.; Blanche, S. 1997: Human immunodeficiency virus-1 infection in neonates: correlation of plasma and cellular viremia and clinical outcome. French Pediatric Cohort Study Group. Acta Paediatrica . Suppl 421: 17-21

De Milito, A.; Catucci, M.; Venturi, G.; Romano, L.; Valensin, P.E.; Zazzi, M.; Almi, P. 1996: Human immunodeficiency virus-1 infection, homosexuality, and Kaposi-associated herpes-like DNA in peripheral blood mononuclear cells. Blood 87(8): 3521-3522

Confalonieri, F.; Villa, A. 1993: Human immunodeficiency virus-associated autonomic neuropathy, drug addiction, and zidovudine treatment. Archives of Internal Medicine 153(3): 400-401

Kishida, S. 2000: Human immunodeficiency virus-associated dementia: review of pathogenesis and treatment studies. No to Shinkei 52(12): 1071-1079

Dalle, J.H.; Dollfus, C.; Courpotin, C.; Tabone, A.M.; Landman-Parker, J.; Leverger, G.; Lasfargues, G. 1994: Human immunodeficiency virus-associated hemophagocytic syndrome in children. Pediatric Infectious Disease Journal 13(12): 1159

Crawford, J.M. 1993: Human immunodeficiency virus-associated periodontal diseases: a review. Journal of Dental Hygiene: Jdh 67(4): 198-207

Sellier, P.; Monsuez, J.J.; Evans, J.; Minozzi, C.; Passeron, J.; Vittecoq, D.; Dussaix, E.; Carcelain, G.; Lacroix-Jousselin, C. 2000: Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy. American Journal of Medicine 109(6): 510-512

Langford, A.; Langer, R.; Lobeck, H.; Stolpmann, H.J.; Pohle, H.D.; Reichart, P.; Bier, J. 1995: Human immunodeficiency virus-associated squamous cell carcinomas of the head and neck presenting as oral and primary intraosseous squamous cell carcinomas. Quintessence International 26(9): 635-654

Donahue, S.P. 1998: Human immunodeficiency virus-associated vision loss: electroretinogram attenuation. American Journal of Ophthalmology 126(5): 729-731

Sasadeusz, J. 2001: Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones. Internal Medicine Journal 31(7): 418-421

Jackson, J.B. 1997: Human immunodeficiency virus-indeterminate western blot and abortive infection. Transfusion 37(1): 1-2

Burris, S. 1996: Human immunodeficiency virus-infected health care workers: the restoration of professional authority. Archives of Family Medicine 5(2): 102-106

Lipton, S.A. 1993: Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Annals of Neurology 33(2): 227-228

Rácz, J.óz.; Ujhelyi, E.; Fehér, B.át. 2002: Human immunodeficiency virus-positive cases among intravenous drug users. Orvosi Hetilap 143(3): 131-133

Salomé, M.A.; Grotto, H.Z.W. 2002: Human immunodeficiency virus-related anemia of chronic disease: relationship to hematologic, immune, and iron metabolism parameters, and lack of association with serum interferon-gamma levels. Aids Patient Care and Stds 16(8): 361-365

Caselli, D.; Klersy, C.; de Martino, M.; Gabiano, C.; Galli, L.; Tovo, P.A.; Aricò, M. 2000: Human immunodeficiency virus-related cancer in children: incidence and treatment outcome--report of the Italian Register. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18(22): 3854-3861

Royce, R. 1996: Human immunodeficiency virus-related morbidity and mortality in injection drug users: should the AIDS definition be changed yet again?. Epidemiology 7(6): 563-565

Werring, D.J.; Chaudhuri, K.R. 1996: Human immunodeficiency virus-related progressive multifocal leukoencephalopathy presenting with an akinetic rigid syndrome. Movement Disorders: Official Journal of the Movement Disorder Society 11(6): 758-761

Lee, L.; Wu, B.; Brett-Smith, H.; Fiedler, P. 1998: Human immunodeficiency virus-related progressive multifocal leukoencephalopathy with a CD4+ of 444 per mm3: a case report. Connecticut Medicine 62(10): 579-582

Punnotok, J.; Shaffer, N.; Naiwatanakul, T.; Pumprueg, U.; Subhannachart, P.; Ittiravivongs, A.; Chuchotthaworn, C.; Ponglertnapagorn, P.; Chantharojwong, N.; Young, N.L.; Limpakarnjanarat, K.; Mastro, T.D. 2000: Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 4(6): 537-543

Gisselbrecht, M.; Cohen, P.; Lortholary, O.; Jarrousse, B.; Gayraud, M.; Lecompte, I.; Ruel, M.; Ghérardi, R.; Guillevin, L. 1998: Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Annales de Medecine Interne 149(7): 398-405

Kotler, D.P. 1998: Human immunodeficiency virus-related wasting: malabsorption syndromes. Seminars in Oncology 25(2 Suppl 6: 70-75

Meng, Y.X.; Lam, L.L.; Kite-Powell, K.; Stamey, F.R.; Pau, C.P.; Pellett, P.E.; Spira, T.J. 2000: Human immunodeficiency virus-seropositive individual with persistent human herpesvirus 8 infection for >11 years without development of Kaposi's sarcoma. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 30(1): 221-222

Lachmann, M. 2002: Human immunodeficiency virus. Emerging epidemic in aboriginal people. Canadian Family Physician Medecin de Famille Canadien 48: 1592-1593; 1600-1601

Ecker-Schlipf, B. 1998: Human immunodeficiency virus. new aspects of pathogenesis. Medizinische Monatsschrift für Pharmazeuten 21(7): 214-216

Griffis, C.A. 1999: Human immunodeficiency virus/acquired immune deficiency syndrome-related drug therapy: anesthetic implications. Crna: the Clinical Forum for Nurse Anesthetists 10(3): 107-116

Morgado, M.G.; Barcellos, C.; Pina, M.d.F.; Bastos, F.I. 2000: Human immunodeficiency virus/acquired immunodeficiency syndrome and tropical diseases: a Brazilian perspective. Memorias do Instituto Oswaldo Cruz 95(Suppl 1): 145-151

Dennis, G.C. 1998: Human immunodeficiency virus/acquired immunodeficiency syndrome crisis. Journal of the National Medical Association 90(11): 643-644

Bally, J.M.G.; Smith, N.R.; Holtslander, L.; Duncan, V.; Hodgson-Viden, H.; Mpofu, C.; Zimmer, M. 2018: A Metasynthesis: Uncovering What Is Known About the Experiences of Families With Children Who Have Life-limiting and Life-threatening Illnesses. Journal of Pediatric Nursing 38: 88-98

Locutura, J.; Francisco Lorenzo, J.; Miján, A. 2001: Human immunodeficiency virus/hepatitis C virus co-infection: do we have the right not to treat our patients?. Enfermedades Infecciosas y Microbiologia Clinica 19(6): 286

Sterne, J.A.; Turner, A.C.; Connell, J.A.; Parry, J.V.; Fine, P.E.; Ponnighaus, J.M.; Nyasulu, S.; Mkandwire, P.K. 1993: Human immunodeficiency virus: GACPAT and GACELISA as diagnostic tests for antibodies in urine. Transactions of the Royal Society of Tropical Medicine and Hygiene 87(2): 181-183

Isaacs, D.; Ziegler, J. 1993: Human immunodeficiency virus: Munchausen by proxy. Pediatric Infectious Disease Journal 12(12): 1038

Mandelbrot, L. 2000: Human immunodeficiency virus: current pregnancy aspects. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 7(Suppl 2): 295s-298s

Kelly, A.M. 1994: Human immunodeficiency virus: current trends in assessment, diagnosis, and treatment. Journal of Intravenous Nursing: the Official Publication of the Intravenous Nurses Society 17(2): 83-92

McKee, J.M. 1996: Human immunodeficiency virus: healthcare worker safety issues. Journal of Intravenous Nursing: the Official Publication of the Intravenous Nurses Society 19(3): 132-140

Penna, P. 1999: Human immunodeficiency virus: managed care steps up to the plate. Managed Care Interface 12(11): 56-57

Parschalk, B.; Pernerstorfer-Schön, H. 1999: Human immunodeficiency virus: post-exposure prophylaxis. Current Opinion in Urology 9(1): 51-55

Kasten, M.J. 2002: Human immunodeficiency virus: the initial physician-patient encounter. Mayo Clinic Proceedings 77(9): 957

Kamat, H.A.; Banker, D.D.; Koppikar, G.V. 2000: Human immunodeficiency viruses types 1 and 2 infection among replacement blood donors in Mumbai (Bombay). Indian Journal of Medical Sciences 54(2): 43-51

McSherry, G.D. 1996: Human immunodeficiency-virus-related pulmonary infections in children. Seminars in Respiratory Infections 11(3): 173-183

Kohata, A. 1994: Human immunoglobulin G carbohydrate chain--its structure, function, and abnormality. Ryumachi 34(2): 167-168

Anonymous 2000: Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis. Prescrire international 9(49): 142-143

Courtney, A.E.; McDonnell, G.V.; Patterson, V.H. 2001: Human immunoglobulin for diabetic amyotrophy--a promising prospect?. Postgraduate Medical Journal 77(907): 326-328

Smith, C.I.; Baskin, B.; Christensson, B.; Sideras, P.; Hammarström, L.; Islam, K.B. 1993: Human immunoglobulin germline alpha(IgA) transcripts are expressed in vivo and their level correlates to class switching. Immunodeficiency 4(1-4): 231-235

Obrador, E.; Peinado, E.; de Kozak, Y.; Ruiz-Moreno, J.M.; Alio, J.L. 1999: Human immunoglobulin preparations for intravenous use prevent endotoxin-induced uveitis in rats. Ophthalmic Research 31(1): 59-67

Gorski, J. 1996: Human immunology special issue: T-cell receptors. Human Immunology 48(1-2): 1-2

Koval'chuk, L.V.; Pabliuk, A.S. 2002: Human immunoregulating (suppressing?) CD4+, CD25+ T lymphocytes ex vivo and in vitro, in the normal state and in pathology. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 40-45

Wartenberg, D.; Laskin, D.; Kipen, H. 1993: Human immunotoxicologic markers of chemical exposures: preliminary validation studies. Journal of Exposure Analysis and Environmental Epidemiology 3(Suppl 1): 51-61

Harada, K.; Glasby, G.P. 2000: Human impact on the environment in Japan and new Zealand: a comparison. Science of the Total Environment 263(1-3): 79-90

Degerman, E.; Hammar, J.; Nyberg, P.; Svärdson, G. 2001: Human impact on the fish diversity in the four largest lakes of Sweden. Ambio 30(8): 522-528

Hadley, E.C.; Dutta, C.; Finkelstein, J.; Harris, T.B.; Lane, M.A.; Roth, G.S.; Sherman, S.S.; Starke-Reed, P.E. 2001: Human implications of caloric restriction's effects on aging in laboratory animals: an overview of opportunities for research. Journals of Gerontology. Series A Biological Sciences and Medical Sciences 56(Special Issue 1): 5-6

Moulon, C.; Péguet-Navarro, J.; Courtellemont, P.; Redziniak, G.; Schmitt, D. 1993: Human in vitro T cell sensitization using hapten-modified epidermal Langerhans cells. Advances in Experimental Medicine and Biology 329: 209-212

Spencer, S. 1983: Human in vitro fertilisation and embryo replacement and transfer. British Medical Journal 286(6380): 1822-1823

Moore, J.W. 1981: Human in vitro fertilization: can we support it?. Christian Century 98(13): 442-446

Englert, Y. 1998: Human in vitro fertilization: technics and ethics. Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 153(12): 436-446; Discussion: 446-447

Boxenbaum, H. 1999: Human in vivo competitive inhibition of P450 substrates: increased plasma concentrations as a function of hepatic extraction ratio and percent inhibition. Journal of Pharmacy and Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences Societe Canadienne des Sciences Pharmaceutiques 2(3): 89-91

Zemtsov, A.; Dixon, L.; Cameron, G. 1994: Human in vivo phosphorus 31 magnetic resonance spectroscopy of psoriasis. a noninvasive tool to monitor response to treatment and to study pathophysiology of the disease. Journal of the American Academy of Dermatology 30(6): 959-965

Brahams, D. 1984: The right to be allowed to die. Lancet 1(8372): 351-352

Park, J.M.; Park, J.H. 2001: Human in-vivo 31P MR spectroscopy of benign and malignant breast tumors. Korean Journal of Radiology 2(2): 80-86

Reiss, S. 2000: Human individuality, happiness, and flow. American Psychologist 55(10): 1161-1162

Dai, W.; Pan, H.; Kwok, O.; Dubey, J.P. 1994: Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. Journal of Interferon Research 14(6): 313-317

Locutura, J.; Ojeda, E.; Lorenzo, J.F.; Palacios, T. 1998: Human infection by Brucella abortus. A common entity?. Enfermedades Infecciosas y Microbiologia Clinica 16(5): 249-250

Schipper, M.A.; Maslen, M.M.; Hogg, G.G.; Chow, C.W.; Samson, R.A. 1996: Human infection by Rhizopus azygosporus and the occurrence of azygospores in Zygomycetes. Journal of medical and veterinary mycology: bi-monthly publication of the International Society for Human and Animal Mycology 34(3): 199-203

Schenone, H. 1998: Human infection by Trypanosoma cruzi in Chile: epidemiology estimates and costs of care and treatment of the chagasic patient. Boletin Chileno de Parasitologia 53(1-2): 23-26

Arzouni, J-Pierre.; Parola, P.; La Scola, B.; Postic, Dèle.; Brouqui, P.; Raoult, D. 2002: Human infection caused by Leptospira fainei. Emerging Infectious Diseases 8(8): 865-868

Formenty, P.; Hatz, C.; Le Guenno, B.; Stoll, A.; Rogenmoser, P.; Widmer, A. 1999: Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation. Journal of Infectious Diseases 179 Suppl. 1: S48-S53

Rupprecht, C.E.; Blass, L.; Smith, K.; Orciari, L.A.; Niezgoda, M.; Whitfield, S.G.; Gibbons, R.V.; Guerra, M.; Hanlon, C.A. 2001: Human infection due to recombinant vaccinia-rabies glycoprotein virus. New England Journal of Medicine 345(8): 582-586

Musso, D.; Drancourt, M.; Bardot, J.; Legré, R. 1994: Human infection due to the CDC group IVc-2 bacterium: case report and review. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 18(3): 482-484

Kemp, M.; Pedersen, B.K.; Theander, T.G. 2000: Human infection immunology. Basic scientific findings and clinical consequences. Ugeskrift for Laeger 162(21): 3020-3023

Waikagul, J.; Wongsaroj, T.; Radomyos, P.; Meesomboon, V.; Praewanich, R.; Jongsuksuntikul, P. 1997: Human infection of Centrocestus caninus in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 28(4): 831-835

Stewart, B.A.. 1997: Human infection with Bartonella species. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 3(6): 677-689

Cacciò, S.; Pinter, E.; Fantini, R.; Mezzaroma, I.; Pozio, E. 2002: Human infection with Cryptosporidium felis: case report and literature review. Emerging Infectious Diseases 8(1): 85-86

Bignall, J. 1994: Human infection with SIV. Lancet 343(8891): 229

Sundsfjord, A.; Simonsen, G.S.; Courvalin, P. 2001: Human infections caused by glycopeptide-resistant Enterococcus spp: are they a zoonosis?. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 7(Suppl 4): 16-33

Tortoli, E.; Bartoloni, A.; Erba, M.L.; Levrè, E.; Lombardi, N.; Mantella, A.; Mecocci, L. 2002: Human infections due to Mycobacterium lentiflavum. Journal of Clinical Microbiology 40(2): 728-729

Alto, W. 2001: Human infections with Angiostrongylus cantonensis. Pacific Health Dialog 8(1): 176-182

Beutin, L.; Zimmermann, S.; Gleier, K. 1998: Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany. Emerging Infectious Diseases 4(4): 635-639

Mandon-Pépin, B.; Derbois, C.; Matsuda, F.; Cotinot, C.; Wolgemuth, D.J.; Smith, K.; McElreavey, K.; Nicolas, A.; Fellous, M. 2002: Human infertility: meiotic genes as potential candidates. Gynecologie Obstetrique and Fertilite 30(10): 817-821

Lomas Cabezas, J.M.; Alcóucer Díaz, R.; Saavedra Martín, J.; Pujol de la Llave, E. 2000: Human infestation by Entamoeba histolytica. Autochthonous disease in our region? Report of a case. Revista Clinica Espanola 200(7): 399

Beshko, N.I.; Pogorel'chuk, T.I.; Man'kovskaia, N.N.; Oleĭnik, V.A. 1994: Human infestation by the nematode Dirofilaria repens. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 1: 58

Fatemi, S.H.; Sidwell, R.; Akhter, P.; Sedgewick, J.; Thuras, P.; Bailey, K.; Kist, D. 1998: Human influenza viral infection in utero increases nNOS expression in hippocampi of neonatal mice. Synapse 29(1): 84-88

Moore, J.T.; Spence, L.M.; Sanders, T.D.; Adams, A.K. 1999: Human influenza: viral mutations and altered tropisms. Clinical Laboratory Science: Journal of the American Society for Medical Technology 12(2): 67-69

Korobeynikov, G. 2002: Human information processing in different age. Bratislavske Lekarske Listy 103(7-8): 244-249

Cooper, R.A.; Aiken, L.H. 2001: Human inputs: the health care workforce and medical markets. Journal of Health Politics Policy and Law 26(5): 925-938

Segizbaeva, M.O.; Isaev, G.G. 2000: Human inspiratory muscle fatigue during strenuous resistance exercise during normo- and hyperoxia. Fiziologiia Cheloveka 26(6): 62-73

Shanks, D.R. 1993: Human instrumental learning: a critical review of data and theory. British Journal of Psychology 84: 319-354

Song, H.Y.; Abad, M.M.; Mahoney, C.P.; McEvoy, R.C. 1999: Human insulin B chain but not a chain decreases the rate of diabetes in BB rats. Diabetes Research and Clinical Practice 46(2): 109-114

Skyler, J.S. 1993: Human insulin after 10 years. Diabetes Care 16(Suppl 3): 1-3

Yasuda, H.; Nagata, M.; Moriyama, H.; Fujihira, K.; Kotani, R.; Yamada, K.; Ueda, H.; Yokono, K. 2001: Human insulin analog insulin aspart does not cause insulin allergy. Diabetes Care 24(11): 2008-2009

Schmauss, S.; König, A.; Landgraf, R. 1998: Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?. Diabetic Medicine: a Journal of the British Diabetic Association 15(3): 247-249

Aujesky, D.; Uebersax, R. 1994: Human insulin and animal-derived insulin--how to establish choices. Revue Medicale de la Suisse Romande 114(6): 547-549

Jørgensen, L.N.; Dejgaard, A.; Pramming, S.K. 1994: Human insulin and hypoglycaemia: a literature survey. Diabetic Medicine: a Journal of the British Diabetic Association 11(10): 925-934

Teuscher, A. 1993: Human insulin and severe hypoglycemias. Deutsche Medizinische Wochenschrift 118(5): 166-167

Itier, J.M.; Douhet, P.; Desbois, P.; Joshi, R.L.; Dandoy-Dron, F.; Jami, J.; Bucchini, D. 1996: Human insulin gene expression in transgenic mice: mutational analysis of the regulatory region. Differentiation; Research in Biological Diversity 60(5): 309-316

Armstrong, M.; Haldane, F.; Taylor, R.W.; Humphriss, D.; Berrish, T.; Stewart, M.W.; Turnbull, D.M.; Alberti, K.G.; Walker, M. 1996: Human insulin receptor substrate-1: variant sequences in familial non-insulin-dependent diabetes mellitus. Diabetic Medicine: a Journal of the British Diabetic Association 13(2): 133-138

Reynolds, R.M.; Walker, B.R. 2003: Human insulin resistance: the role of glucocorticoids. Diabetes Obesity and Metabolism 5(1): 5-12

Jermendy, G.; Nádas, J.; Sápi, Z. 2000: Human insulin-induced lipoatrophy. Orvosi Hetilap 141(44): 2393-2396

Logwin, S.; Conget, I.; Jansa, M.; Vidal, M.; Nicolau, C.; Gomis, R. 1996: Human insulin-induced lipoatrophy. Successful treatment using a jet-injection device. Diabetes Care 19(3): 255-256

Koivisto, V.A. 1994: Human insulin-like growth factor i and treatment in diabetes. Duodecim; Laaketieteellinen Aikakauskirja 110(23-24): 2197-2201

D'Ercole, A.J.; Ye, P.; Dai, Z. 1995: Human insulin-like growth factor binding protein-1 (hIGFBP-1) transgenic mice: insights into hIGFBP-1 regulation and actions. Progress in Growth Factor Research 6(2-4): 417-423

Deary, I.J.. 2001: Human intelligence differences: a recent history. Trends in Cognitive Sciences 5(3): 127-130

Deary, I.J.. 2001: Human intelligence differences: towards a combined experimental-differential approach. Trends in Cognitive Sciences 5(4): 164-170

Marsden, P.; Hollnagel, E. 1996: Human interaction with technology: the accidental user. Acta Psychologica 91(3): 345-358

Kanas, N.; Salnitskiy, V.; Grund, E.M.; Weiss, D.S.; Gushin, V.; Kozerenko, O.; Sled, A.; Marmar, C.R.; Kanas, N. 2001: Human interactions during Shuttle/Mir space missions. Acta Astronautica 48(5-12): 777-784

Kanas, N.; Salnitskiy, V.; Grund, E.M.; Weiss, D.S.; Gushin, V.; Kozerenko, O.; Sled, A.; Marmar, C.R.; Kanas, N. 2001: Human interactions in space: results from Shuttle/Mir. Acta Astronautica 49(3-10): 243-260

White, C. 1998: Human interest at heart. Nursing Times 94(37): 81-84

Anonymous 1982: Human interest program: from clubs to lobster. Review - Federation of American Hospitals 15(2): 42-43

Satava, R.M.; Ellis, S.R. 1994: Human interface technology. An essential tool for the modern surgeon. Surgical Endoscopy 8(7): 817-820

Orinda, G.O.; Wright, I.G.; Leatch, G.; Young, A.S. 1993: Human interferon alpha fails to inhibit the development of Babesia bigemina and Anaplasma marginale infections in cattle. Veterinary Parasitology 47(1-2): 149-155

Adolf, G.R. 1995: Human interferon omega--a review. Multiple Sclerosis 1(Suppl 1): S44-S47

Emanuel, S.L.; Pestka, S. 1993: Human interferon-alpha A, -alpha 2, and -alpha 2(Arg) genes in genomic DNA. Journal of Biological Chemistry 268(17): 12565-12569

Hirata, M.H.; Sackett, D.; Hirata, R.D.; Nguyen, N.Y. 1996: Human interferon-alpha receptor: identification of the region involved in binding to interferon-alpha B. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 16(10): 845-852

Hanibuchi, M.; Nishioka, Y.; Yanagawa, H.; Yano, S.; Parajuli, P.; Bando, M.; Sone, S. 2000: Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity. Oncology Research 12(4): 173-179

Dupuis, S.; Döffinger, R.; Picard, C.; Fieschi, C.; Altare, F.; Jouanguy, E.; Abel, L.; Casanova, J.L. 2000: Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunological Reviews 178: 129-137

Taub, D.D.; Longo, D.L.; Murphy, W.J. 1996: Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. Blood 87(4): 1423-1431

Hattis, D.; Banati, P.; Goble, R.; Burmaster, D.E. 1999: Human interindividual variability in parameters related to health risks. Risk Analysis: An Official Publication of the Society for Risk Analysis 19(4): 711-726

Hattis, D.; Russ, A.; Goble, R.; Banati, P.; Chu, M. 2001: Human interindividual variability in susceptibility to airborne particles. Risk Analysis: An Official Publication of the Society for Risk Analysis 21(4): 585-599

Hattis, D.; Silver, K. 1994: Human interindividual variability--a major source of uncertainty in assessing risks for noncancer health effects. Risk Analysis: An Official Publication of the Society for Risk Analysis 14(4): 421-431

Hawkins, D.L.; MacKay, R.J.; MacKay, S.L.; Moldawer, L.L. 1998: Human interleukin 10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages. Veterinary Immunology and Immunopathology 66(1): 1-10

Lee, Y.; Park, U.S.; Choi, I.; Yoon, S.K.; Park, Y.M.; Lee, Y.I. 1998: Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(7): 1711-1717

Iwasaki, L.R.; Haack, J.E.; Nickel, J.C.; Reinhardt, R.A.; Petro, T.M. 2001: Human interleukin-1 beta and interleukin-1 receptor antagonist secretion and velocity of tooth movement. Archives of Oral Biology 46(2): 185-189

Brown, W.C.; Davis, W.C.; Tuo, W. 1996: Human interleukin-12 upregulates proliferation and interferon-gamma production by parasite antigen-stimulated Th cell clones and gamma/delta T cells of cattle. Annals of the new York Academy of Sciences 795: 321-324

Sun, Z.; Si, J.; Liu, S.; Song, G.; Zheng, S. 1998: Human interleukin-13 cDNA cloning and expression. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 20(5): 371-376

Knezević, M.; Vorauer-Uhl, K.; Hohenwarter, O.; Steindl, F.; Grabherr, R.; Raspor, P. 1996: Human interleukin-2 (IL-2) expressed by transfected mammalian cells. Pflugers Archiv: European Journal of Physiology 431(6 Suppl 2: R227-R228

Burlingham, W.J.; Fechner, J.H.; DeVito, L.D.; Sollinger, H.W.; Knechtle, S.J.; Grailer, A.P. 1993: Human interleukin-2 and lymphoproliferative (T-helper cell) responses to soluble HLA class i antigens in vitro: I. Specificity for polymorphic domains. Tissue Antigens 42(1): 35-38

Wang, Y.; Pei, G.; Cai, Y.C.; Zhao, Z.Q.; Wang, J.B.; Jiang, C.L.; Zheng, Z.C.; Liu, X.Y. 1996: Human interleukin-2 could bind to opioid receptor and induce corresponding signal transduction. Neuroreport 8(1): 11-14

Vie, H.; Gauthier, T.; Breathnach, R.; Bonneville, M.; Godard, A.; Dietrich, J.; Karam, G.; Gesnel, M.C.; Peyrat, M.A.; Jacques, Y. 1993: Human interleukin-2-IgM heavy-chain-fusion proteins are cytotoxic for cells expressing the IL2 receptor. Transplantation Proceedings 25(1 Part 1): 741-742

Weisman, Z.; Evans, D.L.; Jaso-Friedmann, L. 1996: Human interleukin-2-activated adherent natural killer cells recognize a conserved antigen found on tumor cells and protozoan parasites. Natural Immunity 15(6): 269-284

Bertolini, J.N.; Sanderson, C.J.; Benson, E.M. 1993: Human interleukin-5 induces staphylococcal a Cowan 1 strain-activated human B cells to secrete IgM. European Journal of Immunology 23(2): 398-402

Johnson, W.E.B.; Caterson, B.; Eisenstein, S.M.; Hynds, D.L.; Snow, D.M.; Roberts, S. 2002: Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis and Rheumatism 46(10): 2658-2664

Farstad, I.N.; Halstensen, T.S.; Lazarovits, A.I.; Norstein, J.; Fausa, O.; Brandtzaeg, P. 1995: Human intestinal B-cell blasts and plasma cells express the mucosal homing receptor integrin alpha 4 beta 7. Scandinavian Journal of Immunology 42(6): 662-672

Buesen, R.; Mock, M.; Nau, H.; Seidel, A.; Jacob, J.; Lampen, A. 2003: Human intestinal Caco-2 cells display active transport of benzo[a]pyrene metabolites. Chemico-Biological Interactions 142(3): 201-221

Maeurer, M.; Zitvogel, L.; Elder, E.; Storkus, W.J.; Lotze, M.T. 1995: Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA. Natural Immunity 14(4): 188-197

Chen, X.-M.; LaRusso, N.F. 1999: Human intestinal and biliary cryptosporidiosis. World Journal of Gastroenterology 5(5): 424-429

Blumberg, R.S.; Yockey, C.E.; Gross, G.G.; Ebert, E.C.; Balk, S.P. 1993: Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple V beta T cell receptor genes. Journal of Immunology 150(11): 5144-5153

Lorentz, A.; Schwengberg, S.; Sellge, G.; Manns, M.P.; Bischoff, S.C. 2000: Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. Journal of Immunology 164(1): 43-48

Maiga, I.; Doumbo, O.; Dembele, M.; Traoré, H.; Desportes-Livage, I.; Hilmarsdottir, I.; Giboyau, E.; Maiga, L.; Kassambara, L.; el Fakhry, Y.; Datry, A.; Gentilini, M.; Pichard, E. 1997: Human intestinal microsporidiosis in Bamako (Mali): the presence of Enterocytozoon bieneusi in HIV seropositive patients. Sante 7(4): 257-262

De Brito, T.; Sandoval, M.P.; Silva, A.G.; Saad, R.C.; Colaiacovo, W. 1996: Human intestinal spirochetosis. Revista Da Sociedade Brasileira de Medicina Tropical 29(4): 313-317

Svensson, P.; Beydoun, A.; Morrow, T.J.; Casey, K.L. 1997: Human intramuscular and cutaneous pain: psychophysical comparisons. Experimental Brain Research 114(2): 390-392

Pointer, J.S. 1999: Human intraocular pressure and its diurnal variation in healthy subjects. Ophthalmic and Physiological Optics: the Journal of the British College of Ophthalmic Opticians 19 Suppl. 2: S43-S48

Janson, C.G.; Ramesh, T.M.; During, M.J.; Leone, P.; Heywood, J. 2001: Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. Journal of HematoTherapy and Stem Cell Research 10(6): 913-915

Bjorklund, D.F. 2018: A Metatheory for Cognitive Development (or "Piaget is Dead" Revisited). Child Development 89(6): 2288-2302

White, S.A.; Robertson, G.S.; London, N.J.; Dennison, A.R. 2000: Human islet autotransplantation to prevent diabetes after pancreas resection. Digestive Surgery 17(5): 439-450

White, S.A.; James, R.F.; Swift, S.M.; Kimber, R.M.; Nicholson, M.L. 2001: Human islet cell transplantation--future prospects. Diabetic Medicine: a Journal of the British Diabetic Association 18(2): 78-103

Benhamou, P.Y.; Watt, P.C.; Mullen, Y.; Ingles, S.; Watanabe, Y.; Nomura, Y.; Hober, C.; Miyamoto, M.; Kenmochi, T.; Passaro, E.P. 1994: Human islet isolation in 104 consecutive cases. Factors affecting isolation success. Transplantation 57(12): 1804-1810

Casanova, D.; Perojo, I.; Ramos, C.; Erce, C.; Martinez, R.; García, C.; Unzueta, M.T.G.; Amado, J.A. 2002: Human islet isolation in fresh pancreas or after preservation in UW solution. Transplantation Proceedings 34(1): 191-192

Linetsky, E.; Lehmann, R.; Li, H.; Fernandez, L.; Bottino, R.; Selvaggi, G.; Alejandro, R.; Ricordi, C. 1997: Human islet isolation using a new enzyme blend. Transplantation Proceedings 29(4): 1957-1958

Robertson, G.S.; Chadwick, D.; Thirdborough, S.; Swift, S.; Davies, J.; James, R.; Bell, P.R.; London, N.J. 1993: Human islet isolation--a prospective randomized comparison of pancreatic vascular perfusion with hyperosmolar citrate or University of Wisconsin solution. Transplantation 56(3): 550-553

Triponez, F.éd.ér.; Oberholzer, J.é; Toso, C.; Majno, P.; Martin, P.-Y.; Morel, P. 2002: Human islet retransplantation in a patient with type i diabetes. Transplant International: Official Journal of the European Society for Organ Transplantation 15(4): 200-202

Boker, A.; Rothenberg, L.; Hernandez, C.; Kenyon, N.S.; Ricordi, C.; Alejandro, R. 2001: Human islet transplantation: update. World Journal of Surgery 25(4): 481-486

Tyrberg, B.; Eizirik, D.L.; Marklund, S.L.; Olejnicka, B.; Madsen, O.D.; Andersson, A. 1999: Human islets in mixed islet grafts protect mouse pancreatic beta-cells from alloxan toxicity. Pharmacology and Toxicology 85(6): 269-275

Shi, C.L.; Täljedal, I.B.; Nordin, A.; Andersson, A. 2000: Human islets transplanted to nude mice: in vitro insulin release from retrieved grafts. Upsala Journal of Medical Sciences 105(3): 193-206

Harnett, N.; Wan, J.; Brunins, V.; Borczyk, A.; Khakhria, R.; Johnson, W. 1998: Human isolates of Salmonella Typhimurium DT104 in Ontario. Canada Communicable Disease Report 24(3): 20-23

Shekhar, K.C.; Ng, K.P.; Rokiah, I. 1993: Human isosporiasis in an AIDS patient--report of first case in Malaysia. Medical Journal of Malaysia 48(3): 355-360

Salinas, G.; Sinha, K.; Cooper, J.P.; Whitworth, J.A.; Taylor, D.W. 1996: Human isotype antibody responses to an Onchocerca volvulus glutathione S-transferase. Parasite Immunology 18(8): 377-386

Dong, Y.; Kaushal, A.; Bui, L.; Chu, S.; Fuller, P.J.; Nicklin, J.; Samaratunga, H.; Clements, J.A. 2001: Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(8): 2363-2371

Corden, L.D.; McLean, W.H. 1996: Human keratin diseases: hereditary fragility of specific epithelial tissues. Experimental Dermatology 5(6): 297-307

Bachmeier, B.E.; Nerlich, A.G.; Boukamp, P.; Lichtinghagen, R.; Tschesche, H.; Fritz, H.; Fink, E. 2000: Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1. Biological Chemistry 381(5-6): 509-516

Müller, G.; Saloga, J.; Germann, T.; Bellinghausen, I.; Mohamadzadeh, M.; Knop, J.; Enk, A.H. 1995: Human keratinocyte-derived IL-12 affects LC-induced allogeneic T-cell responses. Advances in Experimental Medicine and Biology 378: 519-521

De Bueger, M.; Bakker, A.; Goulmy, E. 1993: Human keratinocytes activate primed major and minor histocompatibility antigen specific Th cells in vitro. Transplant Immunology 1(1): 52-59

Junghans, V.; Jung, T.; Neumann, C. 1996: Human keratinocytes constitutively express IL-4 receptor molecules and respond to IL-4 with an increase in B7/BB1 expression. Experimental Dermatology 5(6): 316-324

Curry, J.L.; Pinto, W.; Nickoloff, B.J.; Slominski, A.T. 2001: Human keratinocytes express functional alpha-MSH (MC1-R) receptors. In Vitro Cellular and Developmental Biology. Animal 37(4): 234-236

van Dijk, A.M.; Otten, H.G.; Ververs, C.; de Boer, M.; Verdonck, L.F.; de Gast, G.C. 1997: Human keratinocytes expressing HLA class II induce short-term anergy toward alloantigens. Transplantation Proceedings 29(1-2): 1027-1028

Stewart, P.M.; Murry, B.A.; Mason, J.I. 1994: Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type i isoform. Journal of Clinical Endocrinology and Metabolism 79(2): 480-484

Diederich, S.; Quinkler, M.; Miller, K.; Heilmann, P.; Schoneshofer, M.; Oelkers, W. 1996: Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin?. European Journal of Endocrinology 134(3): 301-307

Elmore, B.O.; Bollinger, J.A.; Dooley, D.M. 2002: Human kidney diamine oxidase: heterologous expression, purification, and characterization. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 7(6): 565-579

Myara, I.; Cosson, C.; Moatti, N.; Lemonnier, A. 1994: Human kidney prolidase--purification, preincubation properties and immunological reactivity. International Journal of Biochemistry 26(2): 207-214

Duvvuri, U.; Charagundla, S.R.; Kudchodkar, S.B.; Kaufman, J.H.; Kneeland, J.B.; Rizi, R.; Leigh, J.S.; Reddy, R. 2001: Human knee: in vivo T1(rho)-weighted MR imaging at 1.5 T--preliminary experience. Radiology 220(3): 822-826

Allport, V.C.; Pieber, D.; Slater, D.M.; Newton, R.; White, J.O.; Bennett, P.R. 2001: Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Molecular Human Reproduction 7(6): 581-586

Zhang, P.; Sawicki, V.; Lewis, A.; Hanson, L.; Nuijens, J.H.; Neville, M.C. 2001: Human lactoferrin in the milk of transgenic mice increases intestinal growth in ten-day-old suckling neonates. Advances in Experimental Medicine and Biology 501: 107-113

Plaut, A.G.; Qiu, J.; St Geme, J.W. 2000: Human lactoferrin proteolytic activity: analysis of the cleaved region in the IgA protease of Haemophilus influenzae. Vaccine 19(Suppl 1): S148-S152

Signorelli Júnior, A.; Signorelli, C.R.; Muldashev, E.R. 1993: Human lamellar tendon graft in corneal surgery. Refractive and Corneal Surgery 9(2): 135-139

Houdart, R. 1997: Human language and the immaturity of the human brain at birth. Bulletin de l'Academie Nationale de Medecine 181(6): 1153-1159; Discussion: 1159-1161

Hattori, N.; Fujiwara, H.; Maeda, M.; Yoshioka, S.; Higuchi, T.; Mori, T.; Ohishi, N.; Minami, M.; Fujii, S.; Ueda, M. 1998: Human large luteal cells in the menstrual cycle and early pregnancy express leukotriene A4 hydrolase. Molecular Human Reproduction 4(8): 803-810

Keil, A.; Müller, M.M.; Gruber, T.; Wienbruch, C.; Elbert, T. 2001: Human large-scale oscillatory brain activity during an operant shaping procedure. Brain Research. Cognitive Brain Research 12(3): 397-407

Birchall, M. 1998: Human laryngeal allograft: shift of emphasis in transplantation. Lancet 351(9102): 539-540

Strome, M. 2000: Human laryngeal transplantation: considerations and implications. Microsurgery 20(8): 372-374

Beketić-Oresković, L.; Osmak, M. 1994: Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): cross-resistance patterns. Neoplasma 41(3): 171-176

Beketić-Oresković, L.; Osmak, M.; Jaksić, M. 1994: Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance. Neoplasma 41(3): 163-169

Arif, M.; Inooka, H. 1999: Human learning characteristics in the tracking tasks of iterative nature. International Journal of Neural Systems 9(4): 301-310

Lee, B.S.; Nowak, R.A. 2001: Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. Journal of Clinical Endocrinology and Metabolism 86(2): 913-920

Collur, S.; Carroll, A.M.; Cameron, B.D. 2000: Human lens effect on in vivo scanning laser polarimetric measurements of retinal nerve fiber layer thickness. Ophthalmic Surgery and Lasers 31(2): 126-130

Zheng, J.; Liu, Y.; Peng, Y. 1997: Human lens epithelial cells culture in vitro. Yan Ke Xue Bao 13(4): 170-172

Kalariya, N.; Rawal, U.M.; Vasavada, A.R. 1998: Human lens epithelial layer in cortical cataract. Indian Journal of Ophthalmology 46(3): 159-162

Bełtowski, J.; W jcicka, G.; Górny, D.; Marciniak, A. 2002: Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na+, K+-ATPase activity in the rat -- impaired effect in dietary-induced obesity. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 8(6): Br221-Br229

Mathew, I.; Sharma, S.K. 2000: Human leptin deficiency and resistance. Journal of the Association of Physicians of India 48(10): 1032

Ozata, M.; Ozdemir, I.C.; Licinio, J. 1999: Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. Journal of Clinical Endocrinology and Metabolism 84(10): 3686-3695

Burgess, R.E.; Yu, Y.; Christoforidis, G.A.; Bourekas, E.C.; Chakeres, D.W.; Spigos, D.; Kangarlu, A.; Abduljalil, A.M.; Robitaille, P.M. 1999: Human leptomeningeal and cortical vascular anatomy of the cerebral cortex at 8 Tesla. Journal of Computer Assisted Tomography 23(6): 850-856

De Figueiredo, C.M.; Mourão, A.C.; de Oliveira, M.A.; Alves, W.R.; Ooteman, M.C.; Chamone, C.B.; Koury, M.C. 2001: Human leptospirosis in Belo Horizonte City, Minas Gerais, Brazil: a geographic approach. Revista da Sociedade Brasileira de Medicina Tropical 34(4): 331-338

Van, C.T.; Thuy, N.T.; San, N.H.; Hien, T.T.; Baranton, G.; Perolat, P. 1998: Human leptospirosis in the Mekong delta, Viet Nam. Transactions of the Royal Society of Tropical Medicine and Hygiene 92(6): 625-628

Yersin, C.; Bovet, P.; Mérien, F.; Wong, T.; Panowsky, J.; Perolat, P. 1998: Human leptospirosis in the Seychelles (Indian Ocean): a population-based study. American Journal of Tropical Medicine and Hygiene 59(6): 933-940

Suárez Hernández, M.; Martínez Sánchez, R.; Posada Fernández, P.E.; Vidal García, I.; Bravo Fleites, F.; Sánchez Sibello, A. 1999: Human leptospirosis outbreak in the district of Ciego de Avila, Cuba. Revista Da Sociedade Brasileira de Medicina Tropical 32(1): 13-18

Vieira, A.; Barros, M.S.; Valente, C.; Trindade, L.; Faria, M.J.; Freitas, F. 1999: Human leptospirosis. a short review concerning a caseload. Acta Medica Portuguesa 12(12): 331-340

Gemignani, J. 2001: Human lessons from the M&A (merger and acquisition) wars. Business and Health 19(3): 35-39

Coetzee, M.J.; Gordeuk, V.R.; de Kock, A.; Barnard, H.C.; Joubert, G.; Stassen, A.F. 1997: Human leucocyte antigen (HLA) frequencies in rural Venda. South African Medical Journal 87(2): 183-184

Naman, R.E. 1998: Human leucocyte antigen frequencies. Le Journal Medical Libanais. Lebanese Medical Journal 46(1): 52-54

Shankarkumar, U. 2001: Human leucocyte antigen matching and cadaver renal transplantation in India. British Journal of Biomedical Science 58(4): 255

Mao, Y.; Zhang, Z.; Wu, Q. 1997: Human leucocyte antigen-DQA1, -DQB1 polymorphism distribution in Shanghai Chinese women with pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 32(10): 609-612

Grammer, L.C.; Zeiss, C.R.; Yarnold, P.R.; Shaughnessy, M.A. 2000: Human leucocyte antigens (HLA) and trimellitic anhydride (TMA) immunological lung disease. Respiratory Medicine 94(10): 964-970

Del Canho, R.; de Vries, R.R.; Schalm, S.W. 1993: Human leucocyte antigens (HLA) in neonates with an inadequate response to hepatitis B vaccination. Vaccine 11(9): 983

Zola, H. 2001: Human leucocyte differentiation antigens and the human genome project. Journal of Biological Regulators and Homeostatic Agents 15(4): 384-385

Gaeta, G.B.; Di Virgilio, D.; Russo, G.; Stornaiuolo, G.; Nicolella, U.; Colella, F.; Grimaldi, M.; Pasquale, G.; Giusti, G. 1997: Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trial. Journal of Viral Hepatitis 4(3): 209-214

Mazzoran, L.; Zorat, F.; Chemello, L.; Crocè, L.S.; Rigato, I.; Cavalletto, L.; Bernardinello, E.; Tiribelli, C.; Alberti, A.; Pozzato, G. 2001: Human leucocyte interferon-alpha in the treatment of chronic hepatitis C. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 33(4): 347-352

Biswal, B.M.; Kumar, R.; Julka, P.K.; Sharma, U.; Vaidya, M.C. 1998: Human leucocytic antigens (HLA) in breast cancer. Indian Journal of Medical Sciences 52(5): 177-183

Weber, S.; Babina, M.; Feller, G.; Henz, B.M. 1997: Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMC-1 cells. Scandinavian Journal of Immunology 45(5): 471-481

Mathé, G. 1993: Human leukaemogenesis in the vicinity of nuclear installations?. Biomedicine and PharmacoTherapy 47(10): 421-423

Epstein, A. 1993: Human leukemia: re-examination of dogmas. Blood Cells 19(3): 517-520

Babina, M.; Krautheim, M.; Grützkau, A.; Henz, B.M. 2000: Human leukemic (HMC-1) mast cells are responsive to 1alpha, 25-dihydroxyvitamin D(3): selective promotion of ICAM-3 expression and constitutive presence of vitamin D(3) receptor. Biochemical and Biophysical Research Communications 273(3): 1104-1110

Mizuki, N.; Inoko, H. 1995: Human leukocyte antigen (HLA) and the related diseases. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 84(12): 2091-2103

Calvert, G.T.; Shore, E.M. 1998: Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva. Clinical Orthopaedics and Related Research 346: 66-70

Jun, T.-y.; Pae, C.-u.; Chae, J.-h.; Pyo, C.-w.; Han, H. 2002: Human leukocyte antigen alleles in patients with bipolar disorder in the Korean population. Psychiatry and Clinical Neurosciences 56(4): 453-457

Gamir, M.A.; Mallea, I.; Marco, J.; Rubio, F.; Orts, M. 1996: Human leukocyte antigen and otosclerosis. Acta Otorrinolaringologica Espanola 47(1): 26-28

Grandis, J.R.; Falkner, D.M.; Melhem, M.F.; Gooding, W.E.; Drenning, S.D.; Morel, P.A. 2000: Human leukocyte antigen class i allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(7): 2794-2802

Lozano, M.D.; Rubocki, R.J.; Wilson, J.E.; McManus, B.M.; Wisecarver, J.L. 1997: Human leukocyte antigen class II associations in patients with idiopathic dilated cardiomyopathy. Myocarditis Treatment Trial Investigators. Journal of Cardiac Failure 3(2): 97-103

Malak, R.R.; Abdelnoor, A.M. 1997: Human leukocyte antigen frequencies in a selected group of Lebanese Greek Orthodox. Le Journal Medical Libanais. Lebanese Medical Journal 45(2): 78-83

Williams, T.M. 2001: Human leukocyte antigen gene polymorphism and the histocompatibility laboratory. Journal of Molecular Diagnostics: Jmd 3(3): 98-104

Goes, N.; Chandraker, A. 2000: Human leukocyte antigen matching in renal transplantation: an update. Current Opinion in Nephrology and Hypertension 9(6): 683-687

Muscolo, D.L.; Ayerza, M.A.; Calabrese, M.E.; Redal, M.A.; Santini Araujo, E. 1996: Human leukocyte antigen matching, radiographic score, and histologic findings in massive frozen bone allografts. Clinical Orthopaedics and Related Research 326: 115-126

Nelson, K.A. 1996: Human leukocyte antigen system and the immune response to it. Clinical Orthopaedics and Related Research 326: 35-42

Melchiorri, L.; Martini, A.; Rizzo, R.; Berto, A.; Adinolfi, E.; Baricord, O.Roberto. 2002: Human leukocyte antigen-A, -B, -C and -DR alleles and soluble human leukocyte antigen class I serum level in Ménière's disease. Acta Oto-Laryngologica. Supplementum 2002(548): 26-29

Khalil-Daher, I.; Rouas-Freiss, N.; Carosella, E.D.; Dausset, J.B. 2000: Human leukocyte antigen-G: immunotolerant major histocompatibility complex molecule in transplantation. World Journal of Surgery 24(7): 819-822

Krensky, A.M.; Clayberger, C. 1995: Human leukocyte antigen-derived peptides as novel immunosuppressives. Proceedings of the Association of American Physicians 107(1): 81-85

Seneczko, F.; Kaszuba, A.; Trznadel-Budźko, E. 1997: Human leukocyte antigens (HLA) in psoriasis. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 3(16): 210-212

Tisch, M.; Kyrberg, H.; Weidauer, H.; Mytilineos, J.; Conradt, C.; Opelz, G.; Maier, H. 2002: Human leukocyte antigens and prognosis in patients with head and neck cancer: results of a prospective follow-up study. Laryngoscope 112(4): 651-657

Chatzipetrou, M.A.; Tarassi, K.E.; Konstadoulakis, M.M.; Pappas, H.E.; Zafirellis, K.D.; Athanassiades, T.E.; Papadopoulos, S.A.; Panousopoulos, D.G.; Golematis, B.C.; Papasteriades, C.A. 1999: Human leukocyte antigens as genetic markers in colorectal carcinoma. Diseases of the Colon and Rectum 42(1): 66-70

Ohtsuka, K.; Nakamura, Y. 1998: Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients. American Journal of Ophthalmology 126(6): 805-810

Erkan, T.; Kutlu, T.; Yilmaz, E.; Cullu, F.; Tümay, G.T. 1999: Human leukocyte antigens in Turkish pediatric celiac patients. Turkish Journal of Pediatrics 41(2): 181-188

Koriyama, C.; Shinkura, R.; Hamasaki, Y.; Fujiyoshi, T.; Eizuru, Y.; Tokunaga, M. 2001: Human leukocyte antigens related to Epstein-Barr virus-associated gastric carcinoma in Japanese patients. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 10(1): 69-75

Syed, T.A.; Ahmadpour, O.A. 1998: Human leukocyte derived interferon-alpha in a hydrophilic gel for the treatment of intravaginal warts in women: a placebo-controlled, double-blind study. International Journal of Std and Aids 9(12): 769-772

Zola, H. 2001: Human leukocyte differentiation antigens as therapeutic targets: the CD molecules and CD antibodies. Expert Opinion on Biological Therapy 1(3): 375-383

Cai, T.Q.; Wright, S.D. 1996: Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion. Journal of Experimental Medicine 184(4): 1213-1223

Dunder, U.; Mononen, I. 2001: Human leukocyte glycosylasparaginase: cell-to-cell transfer and properties in correction of aspartylglycosaminuria. Febs Letters 499(1-2): 77-81

Frozena, C.L. 1997: Human lice: implications for home health nurses. Home Healthcare Nurse 15(12): 859-862

Helms, J. 1977: Human life amendment. Congressional Record: Proceedings and Debates of the .. Congress. United States. Congress 123(4): S436-S445

Andreotti, G. 1996: Human life and United States' politics. Servir 44(2): 104-105

Escande, D. 1997: Human life and energy production. Prospects opened up by controlled thermonuclear fusion. Bulletin de l'Academie Nationale de Medecine 181(3): 525-537

MacKenzie, J.P.; Donaldson, K. 1974: Testing the right to treatment. Washington Post 1974: C2

Hall, T. 1983: Human life begins: integrated Senate report. Linacre Quarterly 50(3): 253-261

Scorgie, G.G.; Evans Jones, C.F. 1997: Human life is not sheep: an ethical perspective on cloning. Journal of the Evangelical Theological Society. Evangelical Theological Society 40(4): 663-679

Schwartzkopf, S.H.; Schwartzkopf, S.H. 1997: Human life support for advanced space exploration. Advances in Space Biology and Medicine 6: 231-253

Brungs, R. 1982: Human life vs. human personhood. Human Life Review 8(3): 70-80

Horan, D.J. 1981: Human life "federalism" amendments: its language, effects. Hospital Progress 62(12): 12-14

Power, W.E. 1983: Human life--its value and sanctity. C.H.A.C. Review 11(2): 19-20

Curran, C.E. 1974: Human life: the Fifth Commandment. Chicago Studies 13(3): 279-299

Hadfield, J.M.; Yates, D.W.; Kirkman, E.; Little, R.A. 1993: Regional cerebral blood flow and carbon dioxide reactivity after noncerebral injury in the rat. Circulatory Shock 39(2): 100-106

Boukadida, J.; Sboui, H.; Attia, I.; Monastiri, K.; Snoussi, N.; Jeddi, M. 1993: Human listeriosis: 2 new cases in Tunisia and literature review. La Tunisie Medicale 71(4): 213-218

Horvat, R.T.; Zahid, M.A. 1994: Human listeriosis: case report and review. Kansas Medicine: the Journal of the Kansas Medical Society 95(9): 187-8 192

Thöny, B.; Leimbacher, W.; Blau, N.; Heizmann, C.W.; Bürgisser, D. 1993: Human liver 6-pyruvoyl-tetrahydropterin synthase: expression of the cDNA, purification and preliminary characterization of the recombinant protein. Advances in Experimental Medicine and Biology 338: 187-190

Geissler, F.; Jankowska-Gan, E.; DeVito-Haynes, L.D.; Rhein, T.; Kalayoglu, M.; Sollinger, H.W.; Burlingham, W.J. 2001: Human liver allograft acceptance and the "tolerance assay": in vitro anti-donor T cell assays show hyporeactivity to donor cells, but unlike DTH, fail to detect linked suppression. Transplantation 72(4): 571-580

Heilmann, C.; Spamer, C.; Leberer, E.; Gerok, W.; Michalak, M. 1993: Human liver calreticulin: characterization and Zn(2+)-dependent interaction with phenyl-sepharose. Biochemical and Biophysical Research Communications 193(2): 611-616

Herrman, J.L..; Nordlie, P.E..; Nordlie, R.C.. 1971: Human liver carbamyl phosphate-glucose phosphotransferase activity: Catalytic properties and physiological phosphorylative potential. Febs Letters 18(2): 241-244

Bosron, W.F.; Dean, R.A.; Brzezinski, M.R.; Pindel, E.V. 1997: Human liver cocaine carboxylesterases. Nida Research Monograph 173: 27-34

Vereczkey, L.; Jemnitz, K.; Monostory, K. 1997: Human liver cytochrome P-450 and conjugating enzymes. Hungarian data. Acta Physiologica Hungarica 85(2): 149-152

Yamazaki, H.; Shimada, T. 1997: Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers. Biochemical Pharmacology 54(11): 1195-1203

Rath, V.L.; Ammirati, M.; Danley, D.E.; Ekstrom, J.L.; Gibbs, E.M.; Hynes, T.R.; Mathiowetz, A.M.; McPherson, R.K.; Olson, T.V.; Treadway, J.L.; Hoover, D.J. 2000: Human liver glycogen phosphorylase inhibitors bind at a new allosteric site. Chemistry and Biology 7(9): 677-682

Agarwal, D.P.; Eckey, R.; Hempel, J.; Goedde, H.W. 1993: Human liver high Km aldehyde dehydrogenase (ALDH4): properties and structural relationship to the glutamic gamma-semialdehyde dehydrogenase. Advances in Experimental Medicine and Biology 328: 191-197

Angiolillo, A.; Panara, F. 1997: Human liver high molecular weight zinc-dependent acid p-nitrophenylphosphatase. Purification and properties. Biological and Pharmaceutical Bulletin 20(12): 1235-1239

Ono, S.; Hatanaka, T.; Miyazawa, S.; Tsutsui, M.; Aoyama, T.; Gonzalez, F.J.; Satoh, T. 1996: Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 26(11): 1155-1166

Gonzalvo, M.C.; Gil, F.; Hernandez, A.F.; Rodrigo, L.; Villanueva, E.; Pla, A. 1998: Human liver paraoxonase (PON1): subcellular distribution and characterization. Journal of Biochemical and Molecular Toxicology 12(1): 61-69

Chen, X.; Patil, J.G.; Lok, S.H.L.; Kon, O.L. 2002: Human liver-derived cells stably modified for regulated proinsulin secretion function as bioimplants in vivo. Journal of Gene Medicine 4(4): 447-458

Van Schaik, A.; Jin, C.; Carlile, S. 1999: Human localisation of band-pass filtered noise. International Journal of Neural Systems 9(5): 441-446

Newman, D.J.; Alexander, H.L. 1993: Human locomotion and workload for simulated lunar and Martian environments. Acta Astronautica 29(8): 613-620

Inman, V.T.; Inman, V.T. 1993: Human locomotion. 1966. Clinical Orthopaedics and Related Research 288: 3-9

Vartanian, I.A.; Andreeva, I.G.; Markovich, A.M. 2001: Human log-latency auditory evoked potentials during radial motion of the source of sound. Fiziologiia Cheloveka 27(1): 14-21

Battaile, K.P.; McBurney, M.; Van Veldhoven, P.P.; Vockley, J. 1998: Human long chain, very long chain and medium chain acyl-CoA dehydrogenases are specific for the S-enantiomer of 2- methylpentadecanoyl-CoA. Biochimica et Biophysica Acta 1390(3): 333-338

Mikhailova, P. 1984: Human longevity and the demographic aging of the population. Naselenie 2(3): 3-24

Rothschild, H.; Jazwinski, S.M. 1998: Human longevity determinant genes. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 150(6): 272-274

Franceschi, C.; Fabris, N. 1993: Human longevity: the gender difference. Aging 5(5): 333-336

Ho, C.H.; Britt, D.W.; Hlady, V. 1996: Human low density lipoprotein and human serum albumin adsorption onto model surfaces studied by total internal reflection fluorescence and scanning force microscopy. Journal of Molecular Recognition: Jmr 9(5-6): 444-455

Foley, J.M. 1994: Human luminance pattern-vision mechanisms: masking experiments require a new model. Journal of the Optical Society of America. A Optics Image Science and Vision 11(6): 1710-1719

Erger, R.A.; Sahl, B.; Casale, T.B. 1997: Human lung anaphylaxis results in rapid release of interleukin-4. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 78(6): 566-568

Varsano, S.; Rashkovsky, L.; Shapiro, H.; Ophir, D.; Mark-Bentankur, T. 1998: Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance. Clinical and Experimental Immunology 113(2): 173-182

Lechner, J.F.; Wang, Y.; Siddiq, F.; Fugaro, J.M.; Wali, A.; Lonardo, F.; Willey, J.C.; Harris, C.C.; Pass, H.I. 2002: Human lung cancer cells and tissues partially recapitulate the homeobox gene expression profile of embryonic lung. Lung Cancer 37(1): 41-47

Ciernik, I.F.; Berzofsky, J.A.; Carbone, D.P. 1996: Human lung cancer cells endogenously expressing mutant p53 process and present the mutant epitope and are lysed by mutant-specific cytotoxic T lymphocytes. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(5): 877-882

Merkus, P.J.; ten Have-Opbroek, A.A.; Quanjer, P.H. 1996: Human lung growth: a review. Pediatric Pulmonology 21(6): 383-397

Ferrari-Lacraz, S.; Nicod, L.P.; Chicheportiche, R.; Welgus, H.G.; Dayer, J.M. 2001: Human lung tissue macrophages, but not alveolar macrophages, express matrix metalloproteinases after direct contact with activated T lymphocytes. American Journal of Respiratory Cell and Molecular Biology 24(4): 442-451

Koskimies, S. 1980: Human lymphoblastoid cell line producing specific antibody against Rh-antigen D. Scandinavian Journal of Immunology 11(1): 73-77

Furusyo, N.; Hayashi, J.; Ueno, K.; Sawayama, Y.; Kawakami, Y.; Kishihara, Y.; Kashiwagi, S. 1997: Human lymphoblastoid interferon treatment for patients with hepatitis C virus-related cirrhosis. Clinical Therapeutics 19(6): 1352-1367

Vanhoof, G.; Goossens, F.; Juliano, M.A.; Juliano, L.; De Meester, I.; Hendriks, D.; Schatteman, K.; Scharpé, S. 1997: Human lymphocyte X-prolyl aminopeptidase (aminopeptidase P)-like protein. A new member of the proline peptidase family?. Advances in Experimental Medicine and Biology 421: 25-29

Birmele, B.; Thibault, G.; Nivet, H.; Gruel, Y.; Bardos, P.; Lebranchu, Y. 1996: Human lymphocyte adhesion to xenogeneic porcine endothelial cells: modulation by human TNF-alpha and involvement of VLA-4 and LFA-1. Transplant Immunology 4(4): 265-270

Weinberger, A. 1997: Human lymphocyte antigen (HLA) B51 is more frequent in patients with recurrent aphthous stomatitis (RAS). Clinical and Experimental Rheumatology 15(1): 118-119

Quiroz-Mercado, H.; Suárez-Licona, A.; Fromow-Guerra, J.; López-Carasa, G.; Cárdenas-Hernández, R.én.; Ruiz-Morales, J.A.; Portal-Celhay, C.; Granados, J. 2002: Human lymphocyte antigen DR7 protects against proliferative retinopathy with type Ii diabetes mellitus. Archives of Medical Research 33(2): 123-127

Bellorín-Fernández, M.; Fernández-D'Pool, J. 2002: Human lymphocyte chromosome changes induced by x-rays. Investigacion Clinica 43(3): 157-171

Raucy, J.L.; Schultz, E.D.; Wester, M.R.; Arora, S.; Johnston, D.E.; Omdahl, J.L.; Carpenter, S.P. 1997: Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(12): 1429-1435

Yu, D.T.; Clements, P.J.; Paulus, H.E.; Peter, J.B.; Levy, J.; Barnett, E.V. 1974: Human lymphocyte subpopulations. Effect of corticosteroids. Journal of Clinical Investigation 53(2): 565-571

Hattori, N.; Kitagawa, K.; Inagaki, C. 1999: Human lymphocytes express hGH-N gene transcripts of 22kDa, 20kDa and minor forms of GH, but not hGH-V gene. European Journal of Endocrinology 141(4): 413-418

Aguado, B.; Campbell, R.D. 1997: Human lysophosphatidic acid acyltransferase is encoded by a gene located in the major histocompatibility complex. Biochemical Society Transactions 25(4): S597

Pillutla, R.C.; Shimamoto, A.; Furuichi, Y.; Shatkin, A.J. 1998: Human mRNA capping enzyme (RNGTT) and cap methyltransferase (RNMT) map to 6q16 and 18p11.22-p11.23, respectively. Genomics 54(2): 351-353

Simone, J.; Simon, S.; Liao, G.; Matic, M.; Volkman, D. 1993: Human macrophage (M phi) polymorphism demonstrated by differential phagocytosis of fluorescent polystyrene beads. Annals of the new York Academy of Sciences 677: 454-457

Saito, S.; Saito, M.; Enomoto, M.; Ito, A.; Motoyoshi, K.; Nakagawa, T.; Ichijo, M. 1993: Human macrophage colony-stimulating factor induces the differentiation of trophoblast. Growth Factors 9(1): 11-19

Balaz, P.; Friess, H.; Kondo, Y.; Zhu, Z.; Zimmermann, A.; Büchler, M.W. 2002: Human macrophage metalloelastase worsens the prognosis of pancreatic cancer. Annals of Surgery 235(4): 519-527

Maloney, W.J.; James, R.E.; Smith, R.L. 1996: Human macrophage response to retrieved titanium alloy particles in vitro. Clinical Orthopaedics and Related Research 1996(322): 268-278

Nichols, J.E.; Fitzgerald, T.F.; Roberts, N.J. 1993: Human macrophage responses to vaccine strains of influenza virus: synthesis of viral proteins, interleukin-1 beta, interleukin-6, tumour necrosis factor-alpha and interleukin-1 inhibitor. Vaccine 11(1): 36-42

Daulouède, S.; Bouteille, B.; Moynet, D.; De Baetselier, P.; Courtois, P.; Lemesre, J.L.; Buguet, A.; Cespuglio, R.; Vincendeau, P. 2001: Human macrophage tumor necrosis factor (TNF)-alpha production induced by Trypanosoma brucei gambiense and the role of TNF-alpha in parasite control. Journal of Infectious Diseases 183(6): 988-991

Ghia, P.; Schaniel, C.; Rolink, A.G.; Nadler, L.M.; Cardoso, A.A. 1999: Human macrophage-derived chemokine (MDC) is strongly expressed following activation of both normal and malignant precursor and mature B cells. Current Topics in Microbiology and Immunology 246: 103-110

Raposo, Gça.; Moore, M.; Innes, D.; Leijendekker, R.; Leigh-Brown, A.; Benaroch, P.; Geuze, H. 2002: Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3(10): 718-729

Collins, A.R. 1998: Human macrophages are susceptible to coronavirus OC43. Advances in Experimental Medicine and Biology 440: 635-639

Robitaille, P.M.; Abduljalil, A.M.; Kangarlu, A.; Zhang, X.; Yu, Y.; Burgess, R.; Bair, S.; Noa, P.; Yang, L.; Zhu, H.; Palmer, B.; Jiang, Z.; Chakeres, D.M.; Spigos, D. 1998: Human magnetic resonance imaging at 8 T. Nmr in Biomedicine 11(6): 263-265

Gaillard, Y.; Cheze, M.; Pépin, G. 2001: Human main plant poisoning: revue of the literature. Annales de Biologie Clinique 59(6): 764-765

Dorak, M.T.; Chalmers, E.A.; Gaffney, D.; Wilson, D.W.; Galbraith, I.; Henderson, N.; Worwood, M.; Mills, K.I.; Burnett, A.K. 1994: Human major histocompatibility complex contains several leukemia susceptibility genes. Leukemia and Lymphoma 12(3-4): 211-222

Charron, D.; Khalil, I. 1994: Human major histocompatibility complex: the HLA system. La Revue du Praticien 44(1): 20-27

Sirigu, P.; Perra, M.T.; Turno, F. 1995: Human male genitourinary tract: an immunohistochemical study of secretory IgA. Italian Journal of Anatomy and Embryology 100(Suppl 1): 513-518

Belokopytova, I.A.; Kostyleva, E.I.; Tomilin, A.N.; Vorob'ev, V.I. 1993: Human male sterility can be caused by mutations in the protamine P2 gene. Tsitologiia 35(4): 61-67

Woolf, A.S.; Beales, P.L.; Feather, S.A. 1999: Human malformation syndromes: lessons in kidney differentiation. Advances in Nephrology from the Necker Hospital 29: 329-339

Abdiu, A.; Walz, T.M.; Nishikawa, B.K.; Wingren, S.; Larsson, S.E.; Wasteson, A. 1998: Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha and their receptors. European Journal of Cancer 34(13): 2094-2100

Chatterjee, S.; Matsumura, A.; Schradermeier, J.; Gillespie, G.Y. 2000: Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents. Journal of Neuro-Oncology 46(2): 135-144

Allen, G.C.; Brubaker, C.L. 1998: Human malignant hyperthermia associated with desflurane anesthesia. Anesthesia and Analgesia 86(6): 1328-1331

Procopio, A.; Strizzi, L.; Giuffrida, A.; Scarpa, S.; Giuliano, M.; Iezzi, T.; Mutti, L.; Modesti, A. 1998: Human malignant mesothelioma of the pleura: new perspectives for diagnosis and therapy. Monaldi Archives for Chest Disease 53(2): 241-243

Fasth, A.; Porras, O. 1999: Human malignant osteopetrosis: pathophysiology, management and the role of bone marrow transplantation. Pediatric Transplantation 3(Suppl 1): 102-107

Silva, A.L.; Tomé, M.J.; Correia, A.E.; Passos-Coelho, J.L. 2002: Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(3): 422-429

Leighton, J. 1997: Human mammary cancer cell lines and other epithelial cells cultured as organoid tissue in lenticular pouches of reinforced collagen membranes. In Vitro Cellular and Developmental Biology. Animal 33(10): 783-790

Yoshikawa, T.; Ohgushi, H.; Uemura, T.; Nakajima, H.; Ichijima, K.; Tamai, S.; Tateisi, T. 1998: Human marrow cells-derived cultured bone in porous ceramics. Bio-Medical Materials and Engineering 8(5-6): 311-320

Deschaseaux, F.; Charbord, P. 2000: Human marrow stromal precursors are alpha 1 integrin subunit-positive. Journal of Cellular Physiology 184(3): 319-325

Majumdar, M.K.; Thiede, M.A.; Haynesworth, S.E.; Bruder, S.P.; Gerson, S.L. 2000: Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. Journal of HematoTherapy and Stem Cell Research 9(6): 841-848

Horny, H.P.; Kaiserling, E.; Griesser, G.H. 1993: Human mast cells in cases of cutaneous, systemic and malignant mastocytosis do not show immunohistochemically detectable overexpression of p53 protein. British Journal of Haematology 83(3): 524-525

Kanbe, N.; Tanaka, A.; Kanbe, M.; Itakura, A.; Kurosawa, M.; Matsuda, H. 1999: Human mast cells produce matrix metalloproteinase 9. European Journal of Immunology 29(8): 2645-2649

Baram, D.; Vaday, G.G.; Salamon, P.; Drucker, I.; Hershkoviz, R.; Mekori, Y.A. 2001: Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. Journal of Immunology 167(7): 4008-4016

Lin, T.J.; Issekutz, T.B.; Marshall, J.S. 2000: Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. Journal of Immunology 165(1): 211-220

Tsai, C.-M.; Chou, S.-L.; Gale, E.N.; McCall, W.D. 2002: Human masticatory muscle activity and jaw position under experimental stress. Journal of Oral Rehabilitation 29(1): 44-51

Buss, D.M. 2002: Human mate guarding. Neuro Endocrinology Letters 23 Suppl. 4: 23-29

Schmitt, D.P.; Buss, D.M. 2001: Human mate poaching: tactics and tempations for infiltrating existing mateships. Journal of Personality and Social Psychology 80(6): 894-917

Nagase, H.; Fields, G.B. 1996: Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. Biopolymers 40(4): 399-416

Bruyere, K.; Bermond, F.; Bouquet, R.; Caire, Y.; Ramet, M.; Voïglio, E. 2000: Human maxilla bone response to 30 degrees oriented impacts and comparison with frontal bone impacts. Annual Proceedings. Association for the Advancement of Automotive Medicine 44: 219-234

Insausti, R.; Insausti, A.M.; Sobreviela, M.T.; Salinas, A.; Martínez-Peñuela, J.M. 1998: Human medial temporal lobe in aging: anatomical basis of memory preservation. Microscopy Research and Technique 43(1): 8-15

Baatout, S.; Chatelain, B.; Staquet, P.; Symann, M.; Chatelain, C. 1999: Human megakaryocyte polyploidization is associated with a decrease in GPIIIA expression. Anticancer Research 19(6b): 5187-5189

Pörtner, A.; Etchison, J.R.; Sampath, D.; Freeze, H.H. 1996: Human melanoma and Chinese hamster ovary cells galactosylate n-alkyl-beta-glucosides using UDP gal:GlcNAc beta 1,4 galactosyltransferase. Glycobiology 6(1): 7-13

Marchetti, D.; Nicolson, G.L. 1997: Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity. Journal of Investigative Dermatology. Symposium Proceedings 2(1): 99-105

Kern, M.A.; Helmbach, H.; Artuc, M.; Karmann, D.; Jurgovsky, K.; Schadendorf, D. 1997: Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. Anticancer Research 17(6d): 4359-4370

Kamb, A. 1996: Human melanoma genetics. Journal of Investigative Dermatology. Symposium Proceedings 1(2): 177-182

Hiratsuka, J.; Fukuda, H.; Kobayashi, T.; Kanda, K.; Honda, C.; Ichihashi, M.; Mishima, Y. 1996: Human melanoma treated by boron neutron capture therapy: comparison of the clinical response with the predicted response. Radiation Medicine 14(5): 257-263

Ge, H.; Bao, Z. 1996: Human melanoma-specific peptide antigens recognized by HLA-A2 restricted tumor-infiltrating lymphocytes. Zhonghua Yi Xue Za Zhi 76(9): 658-661

Kostich, M.; English, J.; Madison, V.; Gheyas, F.; Wang, L.; Qiu, P.; Greene, J.; Laz, T.M. 2002: Human members of the eukaryotic protein kinase family. Genome Biology 3(9): Research 0043

Yan, Q.; Sadée, W. 2000: Human membrane transporter database: a Web-accessible relational database for drug transport studies and pharmacogenomics. Aaps Pharmsci 2(3): E20

Parkin, A.J. 1999: Human memory. Current Biology: Cb 9(16): R582-R585

Brozek, G. 1997: Human memory and its animal models. Casopis Lekaru Ceskych 136(2): 39-43

Rotenberg, V.S.; Weinberg, I. 1999: Human memory, cerebral hemispheres, and the limbic system: a new approach. Genetic Social and General Psychology Monographs 125(1): 45-70

Adams, E.F.; Hüttner, A.; Lei, T.; Rafferty, B.; Schrell, U.; Fahlbusch, R. 1997: Human meningiomas possess muscarinic acetylcholine receptors: stimulation of phosphatidylinositol turnover by carbachol. Journal of Neuro-Oncology 32(1): 1-6

Verbruggen, G.; Verdonk, R.; Veys, E.M.; Van Daele, P.; De Smet, P.; Van den Abbeele, K.; Claus, B.; Baeten, D. 1996: Human meniscal proteoglycan metabolism in long-term tissue culture. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 4(1): 57-63

Nakata, K.; Shino, K.; Hamada, M.; Mae, T.; Miyama, T.; Shinjo, H.; Horibe, S.; Tada, K.; Ochi, T.; Yoshikawa, H. 2001: Human meniscus cell: characterization of the primary culture and use for tissue engineering. Clinical Orthopaedics and Related Research 2001(391(Suppl): S208-S218

Van Wely, M.; Westergaard, L.G.; Bossuyt, P.M.M.; Van der Veen, F. 2003: Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews 1: Cd003973

Leuenberger, B.; Hahn, D.; Pischitzis, A.; Hansen, M.K.; Sterchi, E.E. 2003: Human meprin beta: O-linked glycans in the intervening region of the type i membrane protein protect the C-terminal region from proteolytic cleavage and diminish its secretion. Biochemical Journal 369(Part 3): 659-665

Ruan, X.Z.; Varghese, Z.; Powis, S.H.; Moorhead, J.F. 1999: Human mesangial cells express inducible macrophage scavenger receptor: an Ap-1 and ets mediated response. Kidney International. Supplement 71: S163-S166

Lee, K.; Majumdar, M.K.; Buyaner, D.; Hendricks, J.K.; Pittenger, M.F.; Mosca, J.D. 2001: Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Molecular Therapy: the Journal of the American Society of Gene Therapy 3(6): 857-866

Mackenzie, T.C.; Flake, A.W. 2001: Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Molecules and Diseases 27(3): 601-604

Reese, J.S.; Koç, O.N.; Gerson, S.L. 1999: Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction. Journal of HematoTherapy and Stem Cell Research 8(5): 515-523

Van den Bos, C.; Mosca, J.D.; Winkles, J.; Kerrigan, L.; Burgess, W.H.; Marshak, D.R. 1997: Human mesenchymal stem cells respond to fibroblast growth factors. Human Cell 10(1): 45-50

Yang, T.T.; Sabokbar, A.; Gibbons, C.L.M.H.; Athanasou, N.A. 2002: Human mesenchymal tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells. Journal of Bone and Joint Surgery. British Volume 84(3): 452-456

Day, A.J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M.R.; Williamson, G. 2001: Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radical Research 35(6): 941-952

Day, A.J.; Williamson, G. 1999: Human metabolism of dietary quercetin glycosides. Basic Life Sciences 66: 415-434

Sun, Y.; Sun, Y.; Wenger, L.; Rutter, J.L.; Brinckerhoff, C.E.; Cheung, H.S. 1999: Human metalloproteinase-1 (collagenase-1) is a tumor suppressor protein p53 target gene. Annals of the New York Academy of Sciences 878: 638-641

Goyette, P.; Sumner, J.S.; Milos, R.; Duncan, A.M.; Rosenblatt, D.S.; Matthews, R.G.; Rozen, R. 1994: Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nature Genetics 7(4): 551

Gabrijelcic-Geiger, D.; Mentele, R.; Meisel, B.; Hinz, H.; Assfalg-Machleidt, I.; Machleidt, W.; Möller, A.; Auerswald, E.A. 2001: Human micro-calpain: simple isolation from erythrocytes and characterization of autolysis fragments. Biological Chemistry 382(12): 1733-1737

Vorob'ev, A.A.; Bykov, A.S.; Boĭchenko, M.N.; Nesvizhskiĭ, I.V.; Pashkov, E.P.; Mironov, A.Iu.; Budanova, E.V.; Seleznev, A.S.; Khoroshko, N.V.; Zudenkov, A.E.; Solntseva, V.K. 2001: Human microecology studies at Department of Microbiology with Virology and Immunology, I.M. Sechenov Moscow Medical Academy. Vestnik Rossiiskoi akademii meditsinskikh nauk 2001(1): 27-31

Morozova, O.A.; Nesterova, M.V.; Aleksandrov, M.T.; Pashkov, E.P. 2001: Human microflora in the norm and in pathology studied with laser fluorescence. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 57-60

Anonymous 2001: Human microphthalmia associated with mutations in the retinal homeobox gene CHX10. Percin EF, Ploder LA, Yu JJ, Arici K, Horsford DJ, Rutherford A, Bapat B, Cox DW, Duncan AMV, Kalnins VI, Kocak-Altintas A, Sowden JC, Trabousli E, Sarfarazi M, McInnes RR.*(1) Nat Gen 2000;25:397-401. American Journal of Ophthalmology 131(1): 156-157

Brasil, P.; de Lima, D.B.; Moura, H. 1997: Human microsporidiosis in the acquired immunodeficiency syndrome. Revista da Associacao Medica Brasileira 43(3): 254-264

Van Gool, T.; Dankert, J. 1995: Human microsporidiosis: Clinical, diagnostic and therapeutic aspects of an increasing infection. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 1(2): 75-85

Boldorini, R.; Tosoni, A. 1998: Human microsporidiosis: emergence of a new opportunistic microorganism in patients infected with the human immunodeficiency virus (HIV). Pathologica 90(4): 412-413

Jackson, C.J.; Nguyen, M. 1997: Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. International Journal of Biochemistry and Cell Biology 29(10): 1167-1177

Hayward, W.A.; Fritz, K.R.; Greene, E.R. 2000: Human middle cerebral artery blood velocity during sexual intercourse. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine 19(12): 871-876

Smither, R. 1982: Human migration and the acculturation of minorities. Human Relations; Studies Towards the Integration of the Social Sciences 35(1): 57-68

Greenwood, M.J. 1985: Human migration: theory, models, and empirical studies. Journal of Regional Science 25(4): 521-544

Rosa Vmp 1977: Human migrations: towards a new theoretical perspective based on the case of the Azores. Economia e Sociologia 23: 51-57

Xanthou, M.; Bines, J.; Walker, W.A. 1995: Human milk and intestinal host defense in newborns: an update. Advances in Pediatrics 42: 171-208

Bernt, K.; Walker, W.A. 2001: Human milk and the response of intestinal epithelium to infection. Advances in Experimental Medicine and Biology 501: 11-30

Chen, H.Y.; Allen, J.C. 2001: Human milk antibacterial factors: the effect of temperature on defense systems. Advances in Experimental Medicine and Biology 501: 341-348

Seifert, E. 1995: Human milk as prevention of intestinal infections in the newborn. Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 14(12): 503

Springer, S. 1997: Human milk banking in Germany. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 13(1): 65-68

Gutiérrez, D.; de Almeida, J.A. 1998: Human milk banks in Brazil. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 14(4): 333-335

Xanthou, M. 1997: Human milk cells. Acta Paediatrica 86(12): 1288-1290

Lyle, R.E.; Kincaid, S.C.; Bryant, J.C.; Prince, A.M.; McGehee, R.E. 2001: Human milk contains detectable levels of immunoreactive leptin. Advances in Experimental Medicine and Biology 501: 87-92

Yuhas, R.; Kuhlman, C.; Jackson, J.; Pramuk, K.; Lien, E. 2000: Human milk fatty acid profiles from Australia, Canada, Japan, and the Philippines. Advances in Experimental Medicine and Biology 478: 399-400

Hylander, M.A.; Strobino, D.M.; Dhanireddy, R. 1998: Human milk feedings and infection among very low birth weight infants. Pediatrics 102(3): E38

Anonymous 1978: Human milk for feeding premature infants: benefits, risks and precautions for a donor program. National Nosocomial Infections Study report 1978: 16-18

Arnold, L.D. 1993: Human milk for premature infants: an important health issue. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 9(2): 121-123

Auerbach, K.G. 1998: Human milk fortifiers are not "nature's way". Journal of Human Lactation: Official Journal of International Lactation Consultant Association 14(2): 99-100

Bier, J.-A.B.; Oliver, T.; Ferguson, A.E.; Vohr, B.R. 2002: Human milk improves cognitive and motor development of premature infants during infancy. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 18(4): 361-367

Qiu, J.; Hendrixson, D.R.; Baker, E.N.; Murphy, T.F.; St Geme, J.W.; Plaut, A.G. 1998: Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proceedings of the National Academy of Sciences of the United States of America 95(21): 12641-12646

Herrera-Insua, I.; Gomez, H.F.; Diaz-Gonzalez, V.A.; Chaturvedi, P.; Newburg, D.S.; Cleary, T.G. 2001: Human milk lipids bind Shiga toxin. Advances in Experimental Medicine and Biology 501: 333-339

Gundacker, C.; Pietschnig, B.; Wittmann, K.J.; Lischka, A. 2000: Human milk mercury (Hg) and lead (Pb) levels in Vienna. Advances in Experimental Medicine and Biology 478: 387-388

Gudiel-Urbano, M.; Goñi, I. 2001: Human milk oligosaccharides. the rule in the health and development of the infants. Archivos Latinoamericanos de Nutricion 51(4): 332-339

Miller, J.B.; McVeagh, P. 1999: Human milk oligosaccharides: 130 reasons to breast-feed. British Journal of Nutrition 82(5): 333-335

Erney, R.; Hilty, M.; Pickering, L.; Ruiz-Palacios, G.; Prieto, P. 2001: Human milk oligosaccharides: a novel method provides insight into human genetics. Advances in Experimental Medicine and Biology 501: 285-297

Duchén, K.; Casas, R.; Fagerås-Böttcher, M.; Yu, G.; Björkstén, B. 2000: Human milk polyunsaturated long-chain fatty acids and secretory immunoglobulin a antibodies and early childhood allergy. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 11(1): 29-39

Torre, P. 1993: Human milk substitutes in Mexican social security services during 1990. Salud Publica de Mexico 35(6): 700-708

Hatløy, A.; Oshaug, A. 1997: Human milk: an invisible food resource. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 13(4): 299-305

Block, M.S.; Finger, I.; Lytle, R. 2002: Human mineralized bone in extraction sites before implant placement: preliminary results. Journal of the American Dental Association 133(12): 1631-1638

De Bueger, M.; Goulmy, E. 1993: Human minor histocompatibility antigens. Transplant Immunology 1(1): 28-38

Larson, E.D.; Drummond, J.T. 2001: Human mismatch repair and G*T mismatch binding by hMutSalpha in vitro is inhibited by adriamycin, actinomycin D, and nogalamycin. Journal of Biological Chemistry 276(13): 9775-9783

Yuasa, Y. 1996: Human mismatch repair genes and HNPCC. Nihon Rinsho. Japanese Journal of Clinical Medicine 54(4): 996-1001

Cooper, A.J.L.; Bruschi, S.A.; Conway, M.; Hutson, S.M. 2003: Human mitochondrial and cytosolic branched-chain aminotransferases are cysteine S-conjugate beta-lyases, but turnover leads to inactivation. Biochemical Pharmacology 65(2): 181-192

Howell, N. 1999: Human mitochondrial diseases: answering questions and questioning answers. International Review of Cytology 186: 49-116

Enríquez, J.A.; Martínez-Azorín, F.; Garesse, R.; López-Pérez, M.J.; Pérez-Martos, A.; Bornstein, B.; Montoya, J. 1998: Human mitochondrial genetic system. Revista de Neurologia 26(Suppl 1): S21-S26

Tully, L.A.; Levin, B.C. 2000: Human mitochondrial genetics. Biotechnology and Genetic Engineering Reviews 17: 147-177

Carosi, G.; Caligaris, S. 1997: Human mobility and sexually transmitted diseases. Medecine Tropicale: Revue du Corps de Sante Colonial 57(2): 115-119

Taylor-Papadimitriou, J.; D'Souza, B.; Berdichevsky, F.; Shearer, M.; Martignone, S.; Alford, D. 1993: Human models for studying malignant progression in breast cancer. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 2(Suppl 3): 77-83

Oligny, L.L. 2001: Human molecular embryogenesis: an overview. Pediatric and Developmental Pathology: the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 4(4): 324-343

Falaschi, P.A. 1997: Human molecular genetics research at the International Centre for Genetic Engineering and Biotechnology. Southeast Asian Journal of Tropical Medicine and Public Health 28(Suppl 2): 14-18

Johnson, J.L.; Rajagopalan, K.V.; Wadman, S.K. 1993: Human molybdenum cofactor deficiency. Advances in Experimental Medicine and Biology 338: 373-378

Donk, M. 1994: Human monitoring behavior in a multiple-instrument setting: independent sampling, sequential sampling or arrangement-dependent sampling. Acta Psychologica 86(1): 31-55

Ivker, R. 1997: Human monkeypox hits beleaguered Zaire. Lancet 349(9053): 709

Anonymous 1997: Human monkeypox in Kasai Oriental, Democratic Republic of the Congo (former Zaire). Preliminary report of October 1997 investigation. Releve epidemiologique hebdomadaire 72(49): 369-372

Anonymous 1997: Human monkeypox in Kasai Oriental, Zaire (1996-1997). Releve Epidemiologique Hebdomadaire 72(15): 101-104

Anonymous 1997: Human monkeypox--Kasai Oriental, Zaire, 1996-1997. Mmwr. Morbidity and Mortality Weekly Report 46(14): 304-307

Callaghan, T.A.; Fleetwood, P.; Contreras, M.; Mollison, P.L.; Scherrmann, J.M. 1993: Human monoclonal anti-D with a normal half-life. Transfusion 33(9): 784-785

Kudo, T. 1994: Human monoclonal antibodies directed to lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(3): 363-368

Kawai, M.; Okada, N. 2002: Human monoclonal antibodies to HIV-1 infection. Nihon Rinsho. Japanese Journal of Clinical Medicine 60(3): 570-577

Thompson, K.; Barden, G.; Sutherland, J.; Beldon, I.; Melamed, M. 1991: Human monoclonal antibodies to human blood group antigens Kidd Jka and Jkb. Transfusion Medicine 1(2): 91-96

Borisova, T.K.; Rosen, A.; Sidorova, E.V. 1999: Human monoclonal antibodies to synthetic viral peptides. Voprosy Virusologii 44(4): 172-174

Burton, D.R.; Barbas, C.F. 1994: Human monoclonal antibodies: recent achievements. Hospital Practice 29(11): 111 114-6 119 Passim

Yoshinari, K.; Aoki, T.; Yamada, H.; Sugawara, I. 1999: Human monoclonal antibody 28K29 highly reactive with lung adenocarcinomas of all grades of differentiation and with large cell carcinomas. Lung Cancer 25(2): 95-103

Trkola, A.; Purtscher, M.; Muster, T.; Ballaun, C.; Buchacher, A.; Sullivan, N.; Srinivasan, K.; Sodroski, J.; Moore, J.P.; Katinger, H. 1996: Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. Journal of Virology 70(2): 1100-1108

Krause, B.J.; Baum, R.P.; Staib-Sebler, E.; Lorenz, M.; Niesen, A.; Hör, G. 1997: Human monoclonal antibody 99mTc-88BV59: detection of colorectal cancer, recurrent or metastatic disease and immunogenicity assessment. European Journal of Nuclear Medicine 24(1): 72-75

Chanock, R.M.; Crowe, J.E.; Murphy, B.R.; Burton, D.R. 1993: Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases. Infectious Agents and Disease 2(3): 118-131

Chang, H.R.; Chavoshan, B.; Park, H. 1993: Human monoclonal antibody SK1-mediated cytotoxicity against colon cancer cells. Diseases of the Colon and Rectum 36(12): 1152-1157

Yamamuro, O.; Goto, S.; Mano, H.; Saito, M.; Watanabe, M.; Nagoya, T.; Tomoda, Y. 1994: Human monoclonal antibody [1-1-2D] against cancer of the uterine cervix. Hybridoma 13(2): 131-137

Wagner, F.F.; Simoneit, K.; Wölpl, A.; Flegel, W.A. 1996: Human monoclonal antibody against enzyme treated erythrocytes. Beitrage Zur Infusionstherapie und Transfusionsmedizin 33: 40-42

Pichurin, P.; Guo, J.; Yan, X.; Rapoport, B.; McLachlan, S.M. 2001: Human monoclonal autoantibodies to B-cell epitopes outside the thyroid peroxidase autoantibody immunodominant region. Thyroid: Official Journal of the American Thyroid Association 11(4): 301-313

Laliberte, R.E.; Perregaux, D.G.; McNiff, P.; Gabel, C.A. 1997: Human monocyte ATP-induced IL-1 beta posttranslational processing is a dynamic process dependent on in vitro growth conditions. Journal of Leukocyte Biology 62(2): 227-239

McCarthy, J.B.; Vachhani, B.V.; Wahl, S.M.; Finbloom, D.S.; Feldman, G.M. 1997: Human monocyte binding to fibronectin enhances IFN-gamma-induced early signaling events. Journal of Immunology 159(5): 2424-2430

Garcia-Zepeda, E.A.; Combadiere, C.; Rothenberg, M.E.; Sarafi, M.N.; Lavigne, F.; Hamid, Q.; Murphy, P.M.; Luster, A.D. 1996: Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. Journal of Immunology 157(12): 5613-5626

Kapur, R.; Lilien, J.; Picciolo, G.L.; Black, J. 1996: Human monocyte morphology is affected by local substrate charge heterogeneity. Journal of Biomedical Materials Research 32(1): 133-142

Rice, P.J.; Kelley, J.L.; Kogan, G.; Ensley, H.E.; Kalbfleisch, J.H.; Browder, I.W.; Williams, D.L. 2002: Human monocyte scavenger receptors are pattern recognition receptors for (1-->3)-beta-D-glucans. Journal of Leukocyte Biology 72(1): 140-146

Chakraborty, A.K.; de Freitas Sousa, J.; Espreafico, E.M.; Pawelek, J.M. 2001: Human monocyte x mouse melanoma fusion hybrids express human gene. Gene 275(1): 103-106

Zhu, K.; Shen, Q.; Ulrich, M.; Zheng, M. 2000: Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines. Chinese Medical Journal 113(12): 1124-1128

Stern, M.; Savill, J.; Haslett, C. 1996: Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. American Journal of Pathology 149(3): 911-921

Vijayagopal, P.; Srinivasan, S.R.; Radhakrishnamurthy, B.; Berenson, G.S. 1993: Human monocyte-derived macrophages bind low-density-lipoprotein-proteoglycan complexes by a receptor different from the low-density-lipoprotein receptor. Biochemical Journal 289: 837-844

Van der Kooij, M.A.; von der Mark, E.M.; Kruijt, J.K.; van Velzen, A.; van Berkel, T.J.; Morand, O.H. 1997: Human monocyte-derived macrophages express an approximately 120-kD Ox-LDL binding protein with strong identity to CD68. Arteriosclerosis Thrombosis and Vascular Biology 17(11): 3107-3116

Rossano, F.; Rizzo, A.; Sanges, M.R.; Cipollaro de L'Ero, G.; Tufano, M.A. 1993: Human monocytes and gingival fibroblasts release tumor necrosis factor-alpha, interleukin-1 alpha and interleukin-6 in response to particulate and soluble fractions of Prevotella melaninogenica and Fusobacterium nucleatum. International Journal of Clinical and Laboratory Research 23(3): 165-168

Kwiatkowski, P.; Artrip, J.H.; Michler, R.E.; Wang, S.F.; McKenzie, I.F.; Sandrin, M.S.; Itescu, S. 2000: Human monocytes bind to ligands on porcine endothelium containing the gal alpha (1,3)-Gal antigen. Transplantation Proceedings 32(5): 931

Gyan, B.; Troye-Blomberg, M.; Perlmann, P.; Björkman, A. 1994: Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediates. Parasite Immunology 16(7): 371-375

Boneberg, E.M.; Hareng, L.; Gantner, F.; Wendel, A.; Hartung, T. 2000: Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 95(1): 270-276

Roundtree, S.E.; Nixon, G.A. 1999: Human monocytic ehrlichiosis in a thirteen year old: a case report. Journal of the South Carolina Medical Association 95(8): 300-302

Schutze, G.E.; Jacobs, R.F. 1997: Human monocytic ehrlichiosis in children. Pediatrics 100(1): E10

Devereaux, C.E. 1997: Human monocytic ehrlichiosis presenting as febrile diarrhea. Journal of Clinical Gastroenterology 25(3): 544-545

Salmon, J.E.; Brogle, N.; Brownlie, C.; Edberg, J.C.; Kimberly, R.P.; Chen, B.X.; Erlanger, B.F. 1993: Human mononuclear phagocytes express adenosine A1 receptors. a novel mechanism for differential regulation of Fc gamma receptor function. Journal of Immunology 151(5): 2775-2785

Xie, H.; Hu, Z.; Chyna, B.; Horrigan, S.K.; Westbrook, C.A. 2000: Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31. Leukemia 14(12): 2128-2134

Ziegler; Chapitis 1998: Human motile sperm recovery after cryopreservation: freezing in nitrogen vapor vs the direct plunge technique. Primary Care Update for Ob/Gyns 5(4): 170

Wang, R.; Huang, C.; Wang, J.; Bai, C.; Yang, N.; Jin, D. 1999: Human motion analysis system based on common video-camera. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 16(4): 448-452

Gandevia, S.C. 1990: Human motor pathways: electrical and electromagnetic stimulation. Current Opinion in Neurology and Neurosurgery 3(5): 765-773

Pahlavan, F.; Bonnet, P.; Duda, D. 2000: Human motor responses to simultaneous aversive stimulation and failure on a valued task. Psychological Reports 86(1): 232-242

Christova, P.; Kossev, A. 2000: Human motor unit activity during concentric and eccentric movements. Electromyography and Clinical Neurophysiology 40(6): 331-338

Christova, P.; Kossev, A. 2001: Human motor unit recruitment and derecruitment during long lasting intermittent contractions. Journal of Electromyography and Kinesiology: Official Journal of the International Society of Electrophysiological Kinesiology 11(3): 189-196

Brown, W.F.; Doherty, T.J.; Chan, M.; Andres, A.; Provost, S.M. 2000: Human motor units in health and disease. Muscle and Nerve. Suppl 9: S7-18

Sharma, L.C.; Muirhead, N.; Lazarovits, A.I. 1997: Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years. Transplantation Proceedings 29(1-2): 323-324

Liu, W.; Yuan, X.G.; Wang, L.G.; Liu, Z.Q.; Wang, R. 2001: Human movement characteristics of target acquisition. Hang Tian Yi Xue Yu Yi Xue Gong Cheng 14(5): 313-317

Masaki, H.; Takasawa, N.; Yamazaki, K. 2000: Human movement-related brain potentials preceding voluntary movements in different arousal states monitored with skin potential level. Perceptual and Motor Skills 90(1): 299-306

Wei, Q.; Zhou, D.H.; Shen, Q.X.; Wang, C.H.; Chen, J.; Li, C.L.; Pei, G.; Chi, Z.Q. 1998: Human mu-opioid receptor overexpressed in baculovirus system and its pharmacological characterizations. Zhongguo Yao Li Xue Bao 19(3): 218-222

Sander, T.; Gscheidel, N.; Wendel, B.; Samochowiec, J.; Smolka, M.; Rommelspacher, H.; Schmidt, L.G.; Hoehe, M.R. 1998: Human mu-opioid receptor variation and alcohol dependence. Alcoholism Clinical and Experimental Research 22(9): 2108-2110

Desseyn, J.L.; Guyonnet-Dupérat, V.; Porchet, N.; Aubert, J.P.; Laine, A. 1997: Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains resulting in a super-repeat. Structural evidence for a 11p15.5 gene family. Journal of Biological Chemistry 272(6): 3168-3178

Chen, Y.; SiTu, Z.; Wu, J. 1996: Human mucoepidermoid carcinoma MEC-1 cells induced differentiation by HMBA. Zhonghua Kou Qiang Yi Xue Za Zhi 31(1): 28-30

Shyjan, A.M.; Bertagnolli, M.; Kenney, C.J.; Briskin, M.J. 1996: Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) demonstrates structural and functional similarities to the alpha 4 beta 7-integrin binding domains of murine MAdCAM-1, but extreme divergence of mucin-like sequences. Journal of Immunology 156(8): 2851-2857

Shenkman, B.S.; Kozlovskaya, I.B.; Nemirovskaya, T.L.; Tcheglova, I.A. 1997: Human muscle atrophy in supportlessness: effects of short-term exposure to dry immersion. Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 4(2): P137-P138

Pampiglione, S.; Cagno, M.C.; Savalli, E.; Guidetti, F. 1996: Human muscle dirofilariasis of difficult diagnosis. Pathologica 88(2): 97-101

Tsintzas, K.; Williams, C. 1998: Human muscle glycogen metabolism during exercise. Effect of carbohydrate supplementation. Sports Medicine 25(1): 7-23

Van den Bogert, A.J.; Gerritsen, K.G.; Cole, G.K. 1998: Human muscle modelling from a user's perspective. Journal of Electromyography and Kinesiology: Official Journal of the International Society of Electrophysiological Kinesiology 8(2): 119-124

Siegel, J.A.; Gilders, R.M.; Staron, R.S.; Hagerman, F.C. 2002: Human muscle power output during upper- and lower-body exercises. Journal of Strength and Conditioning Research 16(2): 173-178

Wong, K.T.; Pathmanathan, R. 1993: Human muscular sarcocystosis in Malaysia. Tropical and Geographical Medicine 45(4): 191

Phillips, J.A.; Hamid, R. 1999: Human mutations and their detection by gene and linkage analysis, allele sharing and association methods. Eastern Mediterranean Health Journal 5(6): 1140-1146

Plancoulaine, S.; Alcaïs, A.; Abel, L.; Casanova, J.L. 2002: Human mycobacterial infections: impact of host genetic factors. Revue Medicale de Liege 57(3): 165-170

Nakajima, H.; Samaridis, J.; Angman, L.; Colonna, M. 1999: Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. Journal of Immunology 162(1): 5-8

Giuliani, N.; Colla, S.; Sala, R.; Moroni, M.; Lazzaretti, M.; La Monica, S.; Bonomini, S.; Hojden, M.; Sammarelli, G.; Barillè, S.; Bataille, R.; Rizzoli, V. 2002: Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. Blood 100(13): 4615-4621

Zhu, Y.; Lai, C.; Wang, J.; Ji, Y.; Wang, H.; Bai, Y. 1993: Human myeloperoxidase gene cDNA cloning and expression in acute leukemia. Chinese Journal of Biotechnology 9(1): 27-32

Valero Aleixandre, M.A.; Vilar Sanchís, D.; Galán-Puchades, M.T.; Fuentes i Ferrer, M.V. 2000: Human myiasis caused by Sarcophagidae sp. (Diptera) in a post-irradiation ulcerative lesion after treatment for an axillary epidermoid carcinoma. Revista Clinica Espanola 200(11): 641-642